Tag Archives: ABBV

Hot Warren Buffett Stocks For 2019

Photo Credit: Forbes.com

Targeting Network Effects

The big news from Berkshire Hathaway (NYSE: BRK.B) (NYSE:BRK.A) last week was Warren Buffett’s targeting of leading ride-hailing firm Uber Technologies (UBER). While the $3B proposed deal ultimately didn’t materialize, the interest from Berkshire is in line with one of Buffett’s preferred investment strategies.

Buffett provided insight into this strategy in his 1989 annual letter to Berkshire shareholders:

In other instances, a great investment opportunity occurs when a marvelous business encounters a one-time huge, but solvable, problem as was the case many years back at both American Express Company (NYSE: AXP) and GEICO. Overall, however, we’ve done better by avoiding dragons than by slaying them.”

Hot Warren Buffett Stocks For 2019: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Shane Hupp]

    News coverage about Siebert Financial (NASDAQ:SIEB) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Siebert Financial earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 47.4698738447738 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Max Byerly]

    News coverage about Siebert Financial (NASDAQ:SIEB) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Siebert Financial earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned media coverage about the financial services provider an impact score of 45.6527746149751 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

  • [By Shane Hupp]

    ValuEngine downgraded shares of Siebert Financial (NASDAQ:SIEB) from a buy rating to a hold rating in a research note published on Tuesday.

    Separately, TheStreet raised shares of Siebert Financial from a d+ rating to a c rating in a report on Wednesday, May 16th.

  • [By Shane Hupp]

    Media stories about Siebert Financial (NASDAQ:SIEB) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Siebert Financial earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.1943735927385 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Hot Warren Buffett Stocks For 2019: Vicon Industries Inc.(VII)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Seven Generations Energy (TSE:VII) insider Glen Allen Nevokshonoff sold 31,319 shares of the business’s stock in a transaction on Thursday, May 10th. The stock was sold at an average price of C$16.15, for a total transaction of C$505,801.85.

  • [By Joseph Griffin]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Kopin alerts:

    Global Microdisplay Market Report 2018-2023 eMagin Corporation, Kopin Corporation, LG Display Co., Ltd., AU … (ittechnology24.com) Price Performance Review on Shares of Kopin Cp (KOPN): Move 3.12% (parkcitycaller.com) MAMA Cross Spotted in Kopin Cp (KOPN) Shares (fisherbusinessnews.com) Is Kopin Corporation (NasdaqGS:KOPN) Generating Enough Return on Equity? (derbynewsjournal.com) Hot Stocks- Vicon Industries, Inc. (NYSE:VII), Kopin Corporation (NASDAQ:KOPN), Mannatech, Incorporated (NASDAQ … (journalfinance.net)

    Shares of Kopin traded up $0.03, reaching $3.34, on Monday, Marketbeat Ratings reports. The stock had a trading volume of 101,064 shares, compared to its average volume of 263,988. Kopin has a fifty-two week low of $2.80 and a fifty-two week high of $4.60.

  • [By Shane Hupp]

    Vicon Industries, Inc. (NYSEAMERICAN:VII) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 249,394 shares, a decrease of 30.9% from the April 30th total of 361,136 shares. Based on an average daily volume of 173,799 shares, the days-to-cover ratio is currently 1.4 days. Approximately 3.0% of the shares of the company are sold short.

Hot Warren Buffett Stocks For 2019: Loews Corporation(L)

Advisors’ Opinion:

  • [By Shane Hupp]

    Laurion Capital Management LP reduced its holdings in Loews Co. (NYSE:L) by 27.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 135,521 shares of the insurance provider’s stock after selling 51,851 shares during the quarter. Laurion Capital Management LP’s holdings in Loews were worth $6,543,000 at the end of the most recent quarter.

  • [By Dan Caplinger]

    Finally, units of Boardwalk Pipeline Partners rose 5%. The master limited partnership has seen its value consistently erode over the past year, but there’s been speculation in the last several months that controlling shareholder Loews (NYSE:L) could choose to buy out the limited partnership units. Some investors have been pleased at the idea of possibly getting a quick bump from recent low share prices, but longer-term unitholders aren’t thrilled about having held on this long only to have Loews buy them out at a bargain price. It’s unclear which side will win out, but today’s move at least makes it clear that investors are paying attention.

  • [By Tyler Crowe]

    It’s not just that its general partner Loews Corporation (NYSE:L) has the ability to do so, It appears that both Boardwalk and Loews are seriously considering this option. Here’s Horton again on the call:

  • [By Garrett Baldwin]

    To see why we believe some of the richest players in the world are preparing for a market collapse, click here.

    Stocks to Watch Today: AMZN, NFLX, AAPL
    Democrats have been enraged by the sweetheart deal given to Amazon.com Inc. (NASDAQ: AMZN) in New York City. Now, independents like former mayor Michael Bloomberg have criticized the billions in subsidies given to the e-commerce giant. Well, Amazon has responded. The company’s executive team is now reevaluating its planned campus in Long Island City, and it could leave the region under pressure. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Brighthouse Financial Inc. (NYSE: BHF), Everest Re Group Ltd. (NYSE: RE), Loews Corp. (NYSE: L), Omega Healthcare Investors Inc. (NYSE: OHI), RCI Hospitality Holdings Inc. (NYSE: RICK), Restaurant Brands International Inc. (NYSE: QSR), and Vornado Realty Trust (NYSE: VNO).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Hot Warren Buffett Stocks For 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    In our chat on Feb. 27, I noted that AbbVie Inc. (NYSE: ABBV) just boosted its dividend by 35%. And I promised I would follow up with a list of more big winners.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

  • [By ]

    Finding Income And Safety From A 5-Time Winner
    The company is drug giant Abbvie (NYSE: ABBV), which is best known for Humira, the rheumatoid arthritis blockbuster.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was AbbVie Inc. (NYSE: ABBV) which rose about 13% to $122.71. The stock’s 52-week range is $59.27 to $125.84. Volume was nearly 18 million compared to the daily average volume of about 5 million.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By ]

    2. AbbVie (NYSE: ABBV)
    This favorite stock of Wall Street has been trading above its 50-day simple moving average (SMA) since November 2016. Even the February sell-off did not cause the price to violate support at the 50-day SMA. This tells me one thing: Big money is watching the primary technical indicator and buying every pull back!

Hot Warren Buffett Stocks For 2019: Huntington Ingalls Industries, Inc.(HII)

Advisors’ Opinion:

  • [By Paul Ausick]

    The carriers are being constructed by Huntington Ingalls Industries Inc. (NYSE: HII) at a total acquisition cost of around $55 billion. Work on the carriers provides more than 20,000 jobs at Huntington’s Newport News shipyard.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Huntington Ingalls Industries (HII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Russell Investments Group Ltd. lowered its position in shares of Huntington Ingalls Industries Inc (NYSE:HII) by 46.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 36,274 shares of the aerospace company’s stock after selling 31,953 shares during the quarter. Russell Investments Group Ltd. owned 0.08% of Huntington Ingalls Industries worth $7,857,000 as of its most recent filing with the SEC.

  • [By Lou Whiteman]

    While no one is suggesting the spigot could be turned off on the Pentagon, the amount of funding the department receives will determine how quickly it moves to refresh its warfighting capabilities. A tight budget could materially impact the revenue outlook for Huntington Ingalls (NYSE:HII), for example, if it means slowing the pace of adding to the Navy fleet, or Lockheed Martin (NYSE:LMT) if the Air Force must stagger its future orders of new warplanes.

  • [By Lou Whiteman]

    Two of the biggest laggards have been General Dynamics (NYSE:GD) and Huntington Ingalls (NYSE:HII), each down by more than 10% in the past three months. The similarities go well beyond stock performance. The companies have two of the more interesting outlooks for growth among defense players, but each seemed to catch investors off guard over how long it will take that increased business to materialize.

Hot Warren Buffett Stocks To Own Right Now

Berkshire Hathaway CEO Warren Buffett (Trades, Portfolio) extolled many of his portfolio holdings for repurchasing their shares, “some quite aggressively,” in his 2016 annual letter. Buffett, who is price-conscious and won’t repurchase his own companies’ shares at more than 1.2 times book value, a statement he last made good on in 2012, approved of his investees’ buybacks because he believes their shares “have in most cases been underpriced.”

NEW YORK, NY – JANUARY 27: Bill Gates and Warren Buffett speak with journalist Charlie Rose at an event organized by Columbia Business School on January 27, 2017 in New York City. Gates and Buffett spoke on a range of topics including their friendship, business, philanthropy, global health, innovation, and leadership. (Photo by Spencer Platt/Getty Images)

Hot Warren Buffett Stocks To Own Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Cory Renauer]

    Gilead Sciences isn’t expecting any top-line revenue growth in 2019 because expiring U.S. patents for Letairis and Ranexa could lead to a loss of around $1.2 billion. The company also expects around $900 million in lost sales because of competition with AbbVie (NYSE:ABBV) for a share of a hepatitis C antiviral (HCV) market that’s been steadily shrinking. Total HCV sales plummeted from $9.1 billion in 2017 to just $3.7 billion in 2018, and Gilead’s new cellular cancer therapy, Yescarta, is proving more difficult to sell than anticipated.

  • [By Cory Renauer]

    The number of American adults over the age of 85 will more than double over the next 22 years and this group’s more dependent on expensive medicines than ever. This long-running megatrend will probably drive overall demand for products from AbbVie Inc. (NYSE:ABBV) and Merk & Co., Inc. (NYSE:MRK) in the right direction for decades to come.

  • [By Michael A. Robinson]

    In our chat on Feb. 27, I noted that AbbVie Inc. (NYSE: ABBV) just boosted its dividend by 35%. And I promised I would follow up with a list of more big winners.

Hot Warren Buffett Stocks To Own Right Now: Cresud S.A.C.I.F. y A.(CRESY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 294,367 shares, a decline of 44.8% from the April 30th total of 533,376 shares. Based on an average daily volume of 179,726 shares, the days-to-cover ratio is presently 1.6 days.

  • [By Stephan Byrd]

    News coverage about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.6414670877177 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Max Byerly]

    Media headlines about Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cresud S.A.C.I.F. y A. earned a coverage optimism score of 0.20 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.7755181744414 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Hot Warren Buffett Stocks To Own Right Now: RetailMeNot, Inc.(SALE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about RetailMeNot (NASDAQ:SALE) have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RetailMeNot earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 45.6302865418039 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Hot Warren Buffett Stocks To Own Right Now: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Ritchie Bros. Auctioneers Inc (NYSE:RBA) (TSE:RBA) – Equities researchers at Jefferies Financial Group reduced their Q3 2018 earnings per share estimates for shares of Ritchie Bros. Auctioneers in a research note issued on Monday, August 13th. Jefferies Financial Group analyst S. Volkmann now forecasts that the business services provider will post earnings of $0.15 per share for the quarter, down from their previous forecast of $0.16. Jefferies Financial Group also issued estimates for Ritchie Bros. Auctioneers’ Q4 2018 earnings at $0.43 EPS, FY2018 earnings at $1.15 EPS, FY2019 earnings at $1.35 EPS and FY2020 earnings at $1.50 EPS.

  • [By Logan Wallace]

    Ritchie Bros. Auctioneers Inc (NYSE:RBA) (TSE:RBA) shares reached a new 52-week high and low on Tuesday . The stock traded as low as $36.00 and last traded at $35.65, with a volume of 9678 shares traded. The stock had previously closed at $35.71.

  • [By Shane Hupp]

    Ritchie Bros. Auctioneers Inc (TSE:RBA) (NYSE:RBA) – Research analysts at Barrington Research increased their FY2019 EPS estimates for Ritchie Bros. Auctioneers in a note issued to investors on Tuesday, August 14th. Barrington Research analyst G. Prestopino now anticipates that the company will earn $1.68 per share for the year, up from their prior forecast of $1.63.

  • [By Max Byerly]

    Ritchie Bros. Auctioneers (NYSE:RBA) (TSE:RBA) last released its quarterly earnings data on Thursday, May 10th. The business services provider reported $0.16 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.01). Ritchie Bros. Auctioneers had a net margin of 10.96% and a return on equity of 12.50%. The business had revenue of $169.80 million during the quarter, compared to analysts’ expectations of $153.56 million. During the same quarter in the prior year, the firm posted $0.12 earnings per share. The firm’s quarterly revenue was up 36.4% on a year-over-year basis. equities research analysts forecast that Ritchie Bros. Auctioneers will post 1.06 EPS for the current year.

Hot Warren Buffett Stocks To Own Right Now: Heartland Financial USA, Inc.(HTLF)

Advisors’ Opinion:

  • [By Logan Wallace]

    Heartland Financial USA Inc (NASDAQ:HTLF) – Stock analysts at Piper Jaffray Companies raised their Q1 2019 earnings per share (EPS) estimates for Heartland Financial USA in a research note issued on Tuesday, January 29th. Piper Jaffray Companies analyst N. Race now expects that the bank will earn $1.03 per share for the quarter, up from their prior forecast of $1.02. Piper Jaffray Companies also issued estimates for Heartland Financial USA’s Q3 2019 earnings at $1.14 EPS, Q4 2019 earnings at $1.15 EPS, FY2019 earnings at $4.42 EPS and FY2020 earnings at $4.77 EPS.

  • [By Stephan Byrd]

    Heartland Financial USA Inc (NASDAQ:HTLF) has been assigned an average rating of “Hold” from the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $53.33.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Heartland Financial USA (HTLF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Heartland Financial USA (HTLF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Casino Stocks To Buy Right Now

Tuesday, June 5, 2018, was a red-letter day in legal sports betting. On that day, Delaware Governor John Carney made history at the Dover Downs casino when he bet $10 on the Philadelphia Phillies beating the Chicago Cubs, and officially made the country’s first legal sports bet outside the state of Nevada.

After Carney placed his bet, all three of Delaware’s casinos – Dover Downs, Harrington Raceway, and the Casino at Delaware Park – were open to take bets on sports like baseball, football, basketball, and hockey.

It was a historic day that Delaware and other states wanted to see for a long time. And for reasons I’ll lay out below, it kicked off an era filled with incredible investment opportunities.

On May 14, 2018, the Supreme Court ruled by a 6-to-3 margin to eliminate the 1992 federal law prohibiting nearly every state from allowing sports betting. The decision is now up to each individual state.

What could this mean for states? Well, in 2017, $4.87 billion was wagered in Nevada, which was the only state allowed to have legal sports betting. That number pales in comparison to the estimated $150 billion that was bet through illegal bookies around the country.

Top 5 Casino Stocks To Buy Right Now: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Billy Duberstein]

    Like the semiconductor and memory industries, the semiconductor equipment industry has consolidated, to a handful of key global players. Two of the largest are U.S. companies Lam Research (NASDAQ:LRCX) and Applied Materials (NASDAQ:AMAT).

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Campbell Soup Company (NYSE: CPB) to report quarterly earnings at $0.61 per share on revenue of $2.14 billion before the opening bell. Campbell Soup shares fell 0.18 percent to $39.15 in after-hours trading.
    Applied Materials, Inc. (NASDAQ: AMAT) reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Applied Materials shares fell 4.48 percent to $51.54 in the after-hours trading session.
    Analysts are expecting Deere & Company (NYSE: DE) to have earned $3.29 per share on revenue of $9.83 billion in the latest quarter. Deere will release earnings before the markets open. Deere shares dropped 1.23 percent to $145.00 in after-hours trading.
    AmTrust Financial Services Inc (NASDAQ: AFSI) shares rose over 5 percent in after-hours trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction. AmTrust Financial shares climbed 5.81 percent to $14.21 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Chris Lange]

    Applied Materials Inc. (NASDAQ: AMAT) is poised to post its most recent quarterly results Thursday. The consensus forecast is $1.14 in EPS and $4.45 billion in revenue. Shares closed at $54.84 apiece. The consensus price target is $70.14, and the 52-week range is $40.79 to $62.40.

  • [By Travis Hoium]

    Shares of semiconductor and display equipment manufacturer Applied Materials, Inc. (NASDAQ:AMAT) fell as much as 10.1% in trading Friday after reporting fiscal second-quarter 2018 earnings and guidance that left investors unimpressed. Shares didn’t recover much throughout the day and were down 9% at 12:20 p.m. EDT. 

  • [By Ashraf Eassa]

    One of the top chip equipment makers is Applied Materials (NASDAQ:AMAT). The company’s share price has taken a beating over the last year as the semiconductor industry — both logic and memory — seems to be suffering from a correction.

Top 5 Casino Stocks To Buy Right Now: Forest City Realty Trust, Inc.(FCE.A)

Advisors’ Opinion:

  • [By Max Byerly]

    Piedmont Office Realty Trust (NYSE: FCE.A) and Forest City Realty Trust (NYSE:FCE.A) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Top 5 Casino Stocks To Buy Right Now: AltaGas Ltd. (ATGFF)

Advisors’ Opinion:

  • [By ]

    AltaGas (OTCPK:ATGFF) agreed to acquire WGL (WGL) in January 2017, and the acquisition is still pending regulatory approval in DC, which is expected mid-2018. WGL operates Washington Gas, the gas utility in the region. The interesting play here I think is AltaGas. It offers a fairly well covered 8.5%+ dividend but has been beaten down as a result of concerns over the price paid for the WGL acquisition and the debt it will be required to take on in the deal. If the WGL acquisition does not receive regulatory approval, it’s very possible that AltaGas goes up. And if WGL is approved, it’s obviously a much better acquisition if Amazon picks anywhere in the DC area, as that should fuel a significant population increase for the gas utility business (some estimates of up to 1 million over 10 to 15 years). The projected growth in the gas utility business can serve as the foundation for AltaGas’s broader operations and allow them to finance debt at more attractive levels going forward. A mere re-rating to a market AFFO multiple would lead to substantial gains from the current 10-20% discount to market AFFO multiples, and a premium driven by the growth in Washington Gas could warrant a 10-20% premium to market AFFO multiples.

  • [By Reuben Gregg Brewer]

    Quarterly dividends are the norm in the United States, and if you’re leaning on dividend income, quarterly budgeting is different from monthly budgeting. However, there’s another option if you look hard enough, with Canadian energy companies Vermilion Energy Inc. (NYSE:VET) and AltaGas Ltd. (NASDAQOTH:ATGFF) offering both monthly dividends and sizable yields.

  • [By Reuben Gregg Brewer]

    If you are looking for high-yield stocks, it’s very likely that Ferrellgas Partners, L.P. (NYSE:FGP) and AltaGas Ltd. (NASDAQOTH:ATGFF) will be of interest to you, sporting impressive yields of 12% and 8.3%, respectively. Often a higher yield is a good thing, but in this situation, you are probably better off going with the lower, though still robust, yield offered by AltaGas. Here’s why.

Top 5 Casino Stocks To Buy Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Keith Speights]

    But if you really prioritize dividend payments, Johnson & Johnson isn’t the best choice. It’s not even the top pick in the healthcare arena. When it comes to dividends, I think investors should look to AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) instead of J&J.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on AbbVie (ABBV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By George Budwell]

    With this theme in mind, here is a look at how AbbVie (NYSE:ABBV) and Celgene Corporation (NASDAQ:CELG) made the two most costly mistakes halfway through 2018 and why investors in these two elite biopharmas shouldn’t necessarily panic over these blunders. 

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) increased to 15.66 million, compared to the previous 15.25 million. The stock was trading at $91.36, in a 52-week range of $64.61 to $125.86.

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) increased slightly to 32.50 million from the previous 32.29 million. The stock was trading at $96.31, and its 52-week range is $69.47 to $125.86.

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) decreased slightly to 31.01 million from the previous 31.37 million. The stock was trading at $94.57, and its 52-week range is $85.24 to $125.86.

Top 5 Casino Stocks To Buy Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Aclaris Therapeutics (NASDAQ:ACRS) have been trending somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aclaris Therapeutics earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the biotechnology company an impact score of 46.9638334424702 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Max Byerly]

    Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania. “

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Aclaris Therapeutics (ACRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Buy For 2019

First Foundation Advisors bought a new stake in Gramercy Property Trust (NYSE:GPT) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,039,224 shares of the real estate investment trust’s stock, valued at approximately $44,312,000. Gramercy Property Trust comprises 2.5% of First Foundation Advisors’ portfolio, making the stock its 9th largest position.

A number of other institutional investors have also added to or reduced their stakes in the business. BlackRock Inc. grew its position in Gramercy Property Trust by 0.3% in the first quarter. BlackRock Inc. now owns 14,439,809 shares of the real estate investment trust’s stock valued at $313,778,000 after acquiring an additional 41,861 shares during the last quarter. Principal Financial Group Inc. grew its position in Gramercy Property Trust by 37.9% in the first quarter. Principal Financial Group Inc. now owns 5,969,108 shares of the real estate investment trust’s stock valued at $129,710,000 after acquiring an additional 1,641,496 shares during the last quarter. Brookfield Asset Management Inc. grew its position in Gramercy Property Trust by 3.4% in the fourth quarter. Brookfield Asset Management Inc. now owns 4,172,980 shares of the real estate investment trust’s stock valued at $111,252,000 after acquiring an additional 136,657 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in Gramercy Property Trust by 9.7% in the first quarter. Massachusetts Financial Services Co. MA now owns 3,195,495 shares of the real estate investment trust’s stock valued at $69,438,000 after acquiring an additional 283,311 shares during the last quarter. Finally, Northern Trust Corp grew its position in Gramercy Property Trust by 4.6% in the first quarter. Northern Trust Corp now owns 2,888,261 shares of the real estate investment trust’s stock valued at $62,762,000 after acquiring an additional 127,801 shares during the last quarter. Hedge funds and other institutional investors own 87.74% of the company’s stock.

Top 10 High Tech Stocks To Buy For 2019: Google Inc.(GOOG)

Advisors’ Opinion:

  • [By Chris Neiger]

    The further we get into 2018, the more we’re starting to see Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Waymo driverless vehicle business taking shape. Since the beginning of this year, the company has announced deals to buy up to tens of thousands of vehicles for its upcoming public ride-hailing service, created a partnership with Avis Budget Group to have its self-driving fleet managed by the rental car company, and even launched a pilot self-driving trucking service for long-haul trucks. 

  • [By Evan Niu, CFA]

    Earlier this month at its I/O developer conference, Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google wowed everyone by demonstrating a new conversational artificial intelligence (AI) technology called Google Duplex, a system that will become part of Google Assistant and will allow the virtual assistant to make phone calls on a user’s behalf. The demonstration was striking because it sounded uncannily human, which has raised all sorts of ethical questions.

  • [By ]

    Other large-cap stocks that have had similar levels of extreme shorting include Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio holding Alphabet Inc. (GOOG) (GOOGL) (then Google) back in late 2004 – shares rallied 112.5% in the year that followed.

  • [By Danny Vena]

    Waymo, the self-driving subsidiary of Google-parent Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), took its first delivery of 100 Chrysler Pacifica minivans supplied by Fiat Chrysler Automobiles (NYSE:FCAU) in December of 2016, adding an additional 500 to its corral in April 2017. Earlier this year, the companies announced that Waymo would be adding “thousands” more minivans to its fleet, though it didn’t specify how many. 

  • [By Evan Niu, CFA]

    Apple (NASDAQ:AAPL) is revamping one of its most controversial services, Apple Maps. The initial rollout of Apple Maps in 2012 was nothing short of a disaster, leading to years of jokes about how bad it was and even contributing to the ouster of former software chief Scott Forstall, who had refused to apologize about the botched launch. CEO Tim Cook had to pen the apology instead. The Mac maker had sparred with Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google at the time over turn-by-turn directions, and Google’s decision to withhold that differentiating feature was the driver of Apple’s decision to make its own mapping service.

Top 10 High Tech Stocks To Buy For 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Neuberger Berman Group LLC lessened its stake in shares of AbbVie Inc (NYSE:ABBV) by 18.7% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 602,168 shares of the company’s stock after selling 138,433 shares during the period. Neuberger Berman Group LLC’s holdings in AbbVie were worth $57,053,000 as of its most recent SEC filing.

  • [By Todd Campbell]

    Let’s turn over to my top pick. My top pick is actually a company called Neurocrine Biosciences, ticker NBIX. The reason why this is my top pick, and it’s really one of my favorite stocks, primarily because I’ve actually been holding on to it for about three years now. I got in early, before Ingrezza got approved. Was really impressed with some of the late stage data. And two, they had a really solid cash position, even at the end of 2015. Then, they also had the backing and credibility of a well-funded partner, which was AbbVie (NYSE:ABBV) at the time, too. That’s still their partner. So, for me, it checked a lot of the boxes. 

  • [By Michael A. Robinson]

    In our chat on Feb. 27, I noted that AbbVie Inc. (NYSE: ABBV) just boosted its dividend by 35%. And I promised I would follow up with a list of more big winners.

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) decreased to 38.44 million, up from the previous 43.50 million. The stock was trading at $92.81, and its 52-week range is $69.38 to $125.86.

Top 10 High Tech Stocks To Buy For 2019: Norwood Financial Corp.(NWFL)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Norwood Financial (NASDAQ:NWFL) have trended somewhat negative this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Norwood Financial earned a coverage optimism score of -0.01 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.6420547965898 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 High Tech Stocks To Buy For 2019: Computer Sciences Corporation(CSC)

Advisors’ Opinion:

  • [By Shane Hupp]

    CasinoCoin (CURRENCY:CSC) traded 26.1% lower against the U.S. dollar during the 24-hour period ending at 23:00 PM E.T. on June 10th. One CasinoCoin coin can currently be bought for about $0.0004 or 0.00000006 BTC on popular exchanges including cfinex and BitFlip. During the last seven days, CasinoCoin has traded 29.9% lower against the U.S. dollar. CasinoCoin has a market capitalization of $15.21 million and $5,864.00 worth of CasinoCoin was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    CasinoCoin (CURRENCY:CSC) traded 11.7% lower against the U.S. dollar during the 24 hour period ending at 21:00 PM ET on May 27th. In the last week, CasinoCoin has traded down 44.1% against the U.S. dollar. One CasinoCoin coin can currently be purchased for $0.0005 or 0.00000007 BTC on popular exchanges including cfinex and BitFlip. CasinoCoin has a market cap of $18.55 million and approximately $27,292.00 worth of CasinoCoin was traded on exchanges in the last day.

Top 10 High Tech Stocks To Buy For 2019: Bryn Mawr Bank Corporation(BMTC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Bryn Mawr Bank Corp. (NASDAQ:BMTC) reached a new 52-week high and low during trading on Wednesday . The company traded as low as $48.00 and last traded at $48.20, with a volume of 762 shares trading hands. The stock had previously closed at $47.85.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Bryn Mawr Bank (BMTC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Bryn Mawr Bank Corp. (NASDAQ:BMTC) has been assigned a consensus rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $53.67.

Top 10 High Tech Stocks To Buy For 2019: SI Financial Group Inc.(SIFI)

Advisors’ Opinion:

  • [By Logan Wallace]

    News coverage about SI Financial Group (NASDAQ:SIFI) has been trending somewhat negative recently, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SI Financial Group earned a media sentiment score of 0.00 on Accern’s scale. Accern also gave news articles about the savings and loans company an impact score of 44.7479870139738 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By ]

    There are 30 banks that qualify as systemically important financial institutions (SIFI), according to the Financial Stability Board’s most recent list. Half have seen their stocks fall at least 20 percent from the most recent peaks, according to a Bloomberg analysis. Notably, no large U.S.-based banks make the list.

  • [By Max Byerly]

    Press coverage about SI Financial Group (NASDAQ:SIFI) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. SI Financial Group earned a news sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the savings and loans company an impact score of 45.140703535879 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Logan Wallace]

    Teton Advisors Inc. acquired a new position in shares of SI Financial Group, Inc. (NASDAQ:SIFI) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 10,342 shares of the savings and loans company’s stock, valued at approximately $153,000. Teton Advisors Inc. owned about 0.08% of SI Financial Group as of its most recent SEC filing.

Top 10 High Tech Stocks To Buy For 2019: American River Bankshares(AMRB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on American River Bankshares (AMRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Media coverage about American River Bankshares (NASDAQ:AMRB) has been trending somewhat positive on Monday, Accern Sentiment reports. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. American River Bankshares earned a news sentiment score of 0.02 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 45.2596868001921 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on American River Bankshares (AMRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    American River Bankshares (NASDAQ:AMRB) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

Top 10 High Tech Stocks To Buy For 2019: Cracker Barrel Old Country Store Inc.(CBRL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Waratah Capital Advisors Ltd. decreased its position in Cracker Barrel (NASDAQ:CBRL) by 94.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,675 shares of the restaurant operator’s stock after selling 45,017 shares during the quarter. Waratah Capital Advisors Ltd.’s holdings in Cracker Barrel were worth $426,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    JPMorgan Chase & Co. boosted its holdings in shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) by 26.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,786 shares of the restaurant operator’s stock after acquiring an additional 14,472 shares during the period. JPMorgan Chase & Co. owned about 0.29% of Cracker Barrel Old Country Store worth $11,109,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    PNC Financial Services Group Inc. lifted its holdings in shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) by 8.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,548 shares of the restaurant operator’s stock after purchasing an additional 371 shares during the period. PNC Financial Services Group Inc.’s holdings in Cracker Barrel Old Country Store were worth $711,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cracker Barrel Old Country Store (CBRL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Demitrios Kalogeropoulos]

    Cracker Barrel (NASDAQ:CBRL) has a customer traffic problem. The restaurant chain recently posted a significant sales volume slump in the fiscal fourth quarter, which pushed revenue lower for the period. The decline caught management by surprise and contributed to a weak operating outlook for the new fiscal year, with Cracker Barrel projecting revenue at existing locations to be roughly flat in 2019.

  • [By Stephan Byrd]

    Marshall Wace LLP boosted its stake in shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) by 10,673.7% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 258,569 shares of the restaurant operator’s stock after buying an additional 256,169 shares during the period. Marshall Wace LLP owned approximately 1.08% of Cracker Barrel Old Country Store worth $40,391,000 as of its most recent filing with the SEC.

Top 10 High Tech Stocks To Buy For 2019: ServiceNow, Inc.(NOW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ServiceNow (NYSE:NOW) has been given a $210.00 price objective by investment analysts at Macquarie in a research report issued on Friday. The firm currently has a “buy” rating on the information technology services provider’s stock. Macquarie’s price objective suggests a potential upside of 13.85% from the stock’s current price.

  • [By Lee Jackson]

    This red-hot momentum stock has had an outstanding year. ServiceNow Inc. (NYSE: NOW) develops and sells a hosted, subscription-based suite of services designed to automate various IT department functions, such as help desk, operations management and change/release management.

  • [By Shane Hupp]

    Shares of ServiceNow Inc (NYSE:NOW) reached a new 52-week high on Tuesday . The stock traded as high as $202.72 and last traded at $199.87, with a volume of 63715 shares trading hands. The stock had previously closed at $198.23.

  • [By ]

    In the Lightning Round, Cramer was bullish on Opko Health (OPK) , Zendesk (ZEN) , ServiceNow (NOW) , Box (BOX) and Constellation Brands (STZ) .

    Cramer was bearish on Thor Industries (THO) and Hain Celestial Group (HAIN) .

  • [By ]

    Zendesk (ZEN) : “Companies love working with them. I like ServiceNow (NOW) but this could be one of our cloud kings too.”

    Box (BOX) : “I still believe in them and that stock goes higher.”

Top 10 High Tech Stocks To Buy For 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Curis (CRIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019

Medical marijuana legalization could be the solution to America’s ongoing opioid epidemic, and that could unlock better than 85% profits for savvy investors…

“You don’t need me to tell you that we’re in the middle of a huge and growing opioid crisis. I’m almost certain you’ve seen the statistics – and you’ve likely seen the evidence yourself,” Money Morning Director of Technology & Venture Capital Research Michael A. Robinson said on June 28, 2017.

From funding substance abuse programs to criminal justice-related costs, the opioid crisis has a staggering economic burden of $78.5 billion, according a 2015 U.S. Department of Health & Human Services (HHS) report.

However, legalizing medical marijuana could be a way to cut the cost of the pricey epidemic, reduce the number of addictions, and provide a profit opportunity for forward-thinking investors.

Top 10 Medical Stocks To Invest In 2019: LaSalle Hotel Properties(LHO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on LaSalle Hotel Properties (LHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Boenning Scattergood reaffirmed their hold rating on shares of LaSalle Hotel Properties (NYSE:LHO) in a research report report published on Friday.

  • [By Paul Ausick]

    LaSalle Hotel Properties (NYSE: LHO) fell about 14% Wednesday to post a new 52-week low of $24.00 after closing at $28.25 on Tuesday. The 52-week high is $31.75. Volume of about 12.2 million was more than 10 times the daily average. The company’s results were hit hard by Hurricane Irma.

Top 10 Medical Stocks To Invest In 2019: Panasonic Corporation (PCRFY)

Advisors’ Opinion:

  • [By ]

    The production issue for batteries may improve with added input from partner Panasonic (OTCPK:PCRFY). They currently produce battery cells for Tesla in Nevada, and in Japan. At their recent earnings call CEO Kazuhiro Tsuga said they were looking at manufacturing battery cells at a new plant in China in conjunction with Tesla. They also predicted their automation energy business profit would double this year. This can be seen as a vote of confidence in Tesla and a bullish sign for Tesla stock. However, according to reports in the Nikkei Asian Review, there is as yet no definite commitment for a joint venture in China. Panasonic is the world’s largest battery supplier for EV’s.

  • [By ]

    However, Panasonic (OTCPK:PCRFY) announced this week that it was happy to consider further investment in the Nevada facility. A similar move in China is not unlikely. Tesla expects to triple its energy storage business this year but its problem has been getting supply to meet the demand. Panasonic’s announcement is probably connected to a very substantial energy storage contract win just announced by the company.

  • [By SEEKINGALPHA.COM]

    JOLED is a company that was established in 2014 by by Japan Display, Sony (NYSE:SNE) and Panasonic (OTCPK:PCRFY). And they are not the only ones:

    During an OLED display Seminar in Korea, UniJet’s CEO Kim Seok-Soon said that new advances in Ink-Jet printing technologies could enable displays that are over 500 PPI – and so make printing a viable technology to produce small and medium-sized OLED panels.

  • [By Ethan Ryder]

    Panasonic (OTCMKTS:PCRFY) was downgraded by equities researchers at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued to investors on Thursday.

  • [By ]

    CBAK is in a very competitive industry, as well as being small relative to its competitors. Among the Company’s competitors are giants like Panasonic (OTCPK:PCRFY) and Samsung (OTC:SSNLF), but overall it faces competition from Japan, Korea, and China. Although CBAK states that “we are able to leverage our low-cost advantage to compete favorably with our competitors”, it is hard to see that being the reality, especially when looking at the above gross margins. Still, the Company may enjoy lower labor costs, since it sources labor locally and apparently it has “higher consistency and safety in product quality, which enables us to compete favorably with local competitors”. But given the greater resources of at least some of its competitors and the constantly evolving dynamics of the industry, competition is surely a risk factor to consider.

Top 10 Medical Stocks To Invest In 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Keith Speights]

    But if you really prioritize dividend payments, Johnson & Johnson isn’t the best choice. It’s not even the top pick in the healthcare arena. When it comes to dividends, I think investors should look to AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) instead of J&J.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Todd Campbell]

    In this prerecorded episode of Industry Focus: Healthcare, host Kristine Harjes and Motley Fool contributor Todd Campbell dive into the world of drug competition. With real-world examples from companies like Merck (NYSE:MRK), AbbVie (NYSE:ABBV), Gilead Sciences (NASDAQ:GILD), and so many more, the hosts explain what investors need to watch to compare similar drugs. Tune in to learn more about the four most important factors to consider — efficacy, safety, price, and convenience.

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) increased to 24.10 million, up from the previous 18.77 million. The stock was trading at $102.52, in a 52-week range of $65.61 to $125.86.

  • [By Keith Speights]

    I’m biased. I wanted to mention that right out of the gate before discussing whether AbbVie (NYSE:ABBV) is a buy. I’ve owned AbbVie for a while and have a favorable view of the big drugmaker’s long-term prospects. However, I’m not oblivious to the challenges AbbVie faces. 

  • [By Keith Speights]

    Which drugs rank at the top of EvaluatePharma’s list? Here are the five biggest blockbusters of the future — and the five companies that are poised to profit from these drugs: AbbVie (NYSE:ABBV), Merck (NYSE:MRK), Celgene (NASDAQ:CELG), Bristol-Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). 

Top 10 Medical Stocks To Invest In 2019: First BanCorp.(FBP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Press coverage about First BanCorp (NYSE:FBP) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. First BanCorp earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 47.5369094230747 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Voya Investment Management LLC lowered its position in First Bancorp (NYSE:FBP) by 83.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 400,520 shares of the bank’s stock after selling 1,959,886 shares during the period. Voya Investment Management LLC owned approximately 0.19% of First Bancorp worth $3,064,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    First Bancorp (NYSE:FBP) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Friday.

Top 10 Medical Stocks To Invest In 2019: New Media Investment Group Inc.(NEWM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on New Media Investment Group (NEWM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Jane Street Group LLC bought a new stake in New Media Investment Group Inc (NYSE:NEWM) in the second quarter, Holdings Channel reports. The fund bought 31,929 shares of the company’s stock, valued at approximately $590,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on New Media Investment Group (NEWM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Formed in 2007, New Media Investment Group (NYSE: NEWM) has spent over $1 billion building its portfolio — acquiring 145 daily newspapers and 340 weekly newspapers across 37 states with a combined reach of over 4 million. Throw in the 538 websites and GateHouse Media, the holding company for New Media, reaches over 22 million people in the United States each week and serves over 200,000 business customers through advertising and related marketing services.

Top 10 Medical Stocks To Invest In 2019: IDT Corporation(IDT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    IDT (NYSE: IDT) and Swisscom (OTCMKTS:SCMWY) are both utilities companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

  • [By Stephan Byrd]

    Swisscom (OTCMKTS: SCMWY) and IDT (NYSE:IDT) are both utilities companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

  • [By Shane Hupp]

    Liberty Sirius XM Group Series A (NASDAQ: LSXMA) and IDT (NYSE:IDT) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk and analyst recommendations.

Top 10 Medical Stocks To Invest In 2019: Valley National Bancorp(VLY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Valley National Bank (NYSE:VLY) announced a quarterly dividend on Tuesday, May 22nd, RTT News reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.11 per share by the financial services provider on Tuesday, July 3rd. This represents a $0.44 annualized dividend and a dividend yield of 3.39%.

  • [By Shane Hupp]

    New Mexico Educational Retirement Board reduced its position in Valley National Bancorp (NYSE:VLY) by 14.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,100 shares of the financial services provider’s stock after selling 10,700 shares during the quarter. New Mexico Educational Retirement Board’s holdings in Valley National Bancorp were worth $755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Swiss National Bank lifted its position in Valley National Bank (NYSE:VLY) by 21.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 544,300 shares of the financial services provider’s stock after purchasing an additional 94,600 shares during the period. Swiss National Bank owned about 0.16% of Valley National Bank worth $6,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Medical Stocks To Invest In 2019: Empire State Realty Trust, Inc.(ESRT)

Advisors’ Opinion:

  • [By ]

    For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT). 

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get Empire State Realty Trust alerts:

    Empire State Realty Trust Inc (ESRT) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Empire State Realty Trust, Inc. (NYSE:ESRT): Tracking the Average Broker Recommendation on This Stock (cantoncaller.com) Empire State Realty Trust Inc (ESRT) Shares Sink -1.41% Over Past Five Sessions (cantoncaller.com) Brokerage Overview of: Empire State Realty Trust inc (NYSE:ESRT) (newburghpress.com) Zacks: Analysts Anticipate Empire State Realty Trust Inc (ESRT) Will Announce Quarterly Sales of $123.37 Million (americanbankingnews.com)

    ESRT opened at $17.55 on Wednesday. The firm has a market cap of $2.94 billion, a P/E ratio of 18.28, a P/E/G ratio of 4.93 and a beta of 0.90. Empire State Realty Trust has a fifty-two week low of $15.94 and a fifty-two week high of $21.09. The company has a debt-to-equity ratio of 0.97, a current ratio of 7.10 and a quick ratio of 7.10.

  • [By Logan Wallace]

    Citadel Advisors LLC grew its holdings in Empire State Realty Trust Inc (NYSE:ESRT) by 109.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,444,342 shares of the real estate investment trust’s stock after purchasing an additional 1,801,601 shares during the quarter. Citadel Advisors LLC’s holdings in Empire State Realty Trust were worth $58,899,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Prudential Financial Inc. cut its stake in Empire State Realty (NYSE:ESRT) by 0.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,745,889 shares of the real estate investment trust’s stock after selling 8,046 shares during the quarter. Prudential Financial Inc.’s holdings in Empire State Realty were worth $29,313,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Empire State Realty Trust (ESRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Empire State Realty Trust, Inc. (NYSE:ESRT), a leading real estate investment trust (REIT), owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the world's most famous building. Headquartered in New York, New York, the Company's office and retail portfolio covers 10.1 million rentable square feet, as of March 31, 2018, consisting of 9.4 million rentable square feet in 14 office properties, including nine in Manhattan, three in Fairfield County, Connecticut, and two in Westchester County, New York; and approximately 700,000 rentable square feet in the retail portfolio.

Top 10 Medical Stocks To Invest In 2019: Duff & Phelps Utilities Income, Inc.(DNP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Stratos Wealth Partners LTD. lifted its holdings in DNP Select Income Fund Inc. Common Stock (NYSE:DNP) by 108.1% during the first quarter, Holdings Channel reports. The institutional investor owned 17,485 shares of the investment management company’s stock after purchasing an additional 9,084 shares during the period. Stratos Wealth Partners LTD.’s holdings in DNP Select Income Fund Inc. Common Stock were worth $180,000 as of its most recent filing with the SEC.

Top 10 Medical Stocks To Invest In 2019: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.

Top 10 Value Stocks To Buy For 2018

BidaskClub upgraded shares of Tecnoglass (NASDAQ:TGLS) from a strong sell rating to a sell rating in a report issued on Wednesday morning.

Other equities research analysts have also recently issued reports about the company. Zacks Investment Research raised Tecnoglass from a hold rating to a buy rating and set a $10.00 target price on the stock in a report on Thursday, April 19th. ValuEngine raised Tecnoglass from a hold rating to a buy rating in a report on Monday, April 2nd. Finally, B. Riley initiated coverage on Tecnoglass in a report on Tuesday, March 6th. They issued a buy rating and a $11.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Tecnoglass has a consensus rating of Hold and a consensus target price of $10.50.

Top 10 Value Stocks To Buy For 2018: GasLog LP.(GLOG)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get GasLog alerts:

    Validea’s Top Five Energy Stocks Based On Peter Lynch – 5/13/2018 (nasdaq.com) GasLog Ltd. (GLOG): Stock in Featured Spotlight: (stockquote.review) Is it time to Sell Now? GasLog Ltd. (GLOG) (nysestocks.review) BRIEF-Gaslog Partners Announces Election Of Director (reuters.com) GasLog Partners LP Announces Election of Director at 2018 Annual Meeting of Limited Partners (nasdaq.com)

    A number of research firms have commented on GLOG. Morgan Stanley downgraded shares of GasLog from an “overweight” rating to an “equal weight” rating and set a $20.00 target price for the company. in a research report on Monday, February 12th. They noted that the move was a valuation call. Zacks Investment Research raised shares of GasLog from a “sell” rating to a “hold” rating in a research report on Monday, March 12th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $20.00 target price (up previously from $19.00) on shares of GasLog in a research report on Saturday, February 17th. Jefferies Group reaffirmed a “buy” rating and issued a $24.00 target price on shares of GasLog in a research report on Friday, January 26th. Finally, Seaport Global Securities reaffirmed a “buy” rating and issued a $23.00 target price on shares of GasLog in a research report on Friday, February 23rd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $20.30.

  • [By Ethan Ryder]

    GasLog (NYSE:GLOG) has been assigned a consensus rating of “Hold” from the nine analysts that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $20.30.

Top 10 Value Stocks To Buy For 2018: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By ]

    But stocks like Abbvie (Nasdaq: ABBV) offer the best of both worlds — a current yield that is already double the market average plus an impressive 23% annual dividend growth rate. Since it was spun off from Abbot Labs in 2013, the pharmaceutical company has grown by leaps and bounds, growing top-line revenues by more than $10 billion.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on AbbVie (ABBV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cheviot Value Management LLC cut its stake in shares of AbbVie Inc. (NYSE:ABBV) by 8.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,818 shares of the company’s stock after selling 5,054 shares during the quarter. AbbVie comprises approximately 2.8% of Cheviot Value Management LLC’s investment portfolio, making the stock its 10th biggest holding. Cheviot Value Management LLC’s holdings in AbbVie were worth $5,398,000 at the end of the most recent reporting period.

  • [By WWW.GURUFOCUS.COM]

    For the details of MENLO ADVISORS LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=MENLO+ADVISORS+LLC

    These are the top 5 holdings of MENLO ADVISORS LLCBerkshire Hathaway Inc (BRK.B) – 103,443 shares, 15.75% of the total portfolio. Shares reduced by 0.25%Bank of America Corporation (BAC) – 241,490 shares, 5.48% of the total portfolio. Shares reduced by 0.25%Markel Corp (MKL) – 6,158 shares, 5.39% of the total portfolio. Shares reduced by 0.39%AbbVie Inc (ABBV) – 70,185 shares, 5.21% of the total portfolio. Shares reduced by 2.16%Cisco Systems Inc (CSCO) – 165,414 shares, 4.87% o

  • [By Cory Renauer]

    SinceAbbVie Inc.’s (NYSE:ABBV) inception, investors have been fretting about the eventual demise of its lead drug, Humira. The aging blockbuster has slowed down a bit during the first three months of the year, but the rest of the company’s product lineup stepped up and delivered.

Top 10 Value Stocks To Buy For 2018: UNITIL Corporation(UTL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Pacific Gas and Electric (NYSE: PCG) and Unitil (NYSE:UTL) are both utilities companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Top 10 Value Stocks To Buy For 2018: Navigant Consulting, Inc.(NCI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Navigant Consulting (NYSE:NCI) was upgraded by Barrington Research from a “market perform” rating to an “outperform” rating in a research note issued on Monday, The Fly reports.

  • [By Joseph Griffin]

    Booz Allen Hamilton (NYSE: BAH) and Navigant Consulting (NYSE:NCI) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, risk and institutional ownership.

  • [By Shane Hupp]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Navigant Consulting alerts:

    Navigant Recognized as Insurance Expert Witness Firm of the Year and Seven Thought Leaders Honored across Three Categories (finance.yahoo.com) Navigant Consulting Inc.: Alma Angotti and Salvatore LaScala Named Co-Leaders of Navigants Global Investigations and Compliance Practice (twst.com) Critical Review: Navigant Consulting (NCI) & Genpact (G) (americanbankingnews.com) Navigant Rides on Technology Investment Amid Staffing Issues (finance.yahoo.com)

    NYSE:NCI opened at $23.59 on Thursday. The company has a market cap of $1.06 billion, a PE ratio of 21.64, a P/E/G ratio of 1.34 and a beta of 0.92. Navigant Consulting has a fifty-two week low of $23.45 and a fifty-two week high of $23.63. The company has a quick ratio of 2.60, a current ratio of 2.60 and a debt-to-equity ratio of 0.27.

Top 10 Value Stocks To Buy For 2018: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Quality Systems (QSII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Buy For 2018: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Mackay Shields LLC acquired a new stake in Jabil (NYSE:JBL) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 743,100 shares of the technology company’s stock, valued at approximately $21,349,000.

  • [By Rich Duprey]

    And the licensing deal with Jabil (NYSE: JBL), which makes GoPro cameras, to have the camera tech added into third-party devices, expands the window of opportunity further.

  • [By Peter Graham]

    Nevertheless, a long term performance chart shows Sanmina Corp previously being an outperformer, but now falling off whilepotential large cap peer Flextronics International Ltd (NASDAQ: FLEX) has given a steady performance over the last two years and small capCelestica Inc (NYSE: CLS) and mid capJabil Circuit, Inc (NYSE: JBL) have similar unaspiring charts:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners (albeit FLEX has steadily risen for two years while SANM has already peaked) compared with the moderately positive performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

Top 10 Value Stocks To Buy For 2018: Global Eagle Entertainment Inc.(ENT)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Retail stocks are in focus after the U.S. Census Bureau released monthly sales figures before the bell Tuesday. The bureau said that retail sales increased by 0.3% in April, a figure that matched trade expectations. Markets had expected consumer spending to increase, however home improvement sales were not the major factor that most expected. This was evident from The Home Depot’s earnings report. Markets are increasingly optimistic over U.S. trade negotiations with China. Chinese President Xi Jinping’s No. 1 economic advisor will visit the United States this week to continue the nation’s dialogue with America. In addition, roughly 100 companies and trade associations will be sounding off to the Trump administration about the potential impact of tariffs in the Chinese markets.
    Stocks to Watch Today: TSLA, AMZN, GS
    Amazon.com Inc. (Nasdaq: AMZN) is in focus thanks to tax policy in Seattle. On Monday, the Seattle’s City Council passed a bill that will tax Amazon and 131 other companies $275 per employee each year in order to create a fund to address homelessness in the Seattle. The tax is half what was originally proposed and remains a contentious issue for Amazon, which is the city’s biggest employer. Goldman Sachs Group (NYSE: GS) is sounding the alarm about the state of the markets. The company warned that the U.S. budget deficit is increasing while America’s unemployment rate is falling. This hasn’t occurred since the World War II. The bank believes that the combination of the two could cause the Fed to spike interest rates in the near future. This comes at a time when the Fed has already lost control of interest rates. Look for additional earnings reports from Eagle Materials Inc. (NYSE: EXP), Bitauto Holding Ltd.(Nasdaq: BITA), Virtusa Corp. (Nasdaq: VRTU), Global Eagle Entertainment Inc.(Nasdaq: ENT), and Kamada Ltd. (Nasdaq: KMDA).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

Top 10 Value Stocks To Buy For 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

Top 10 Value Stocks To Buy For 2018: AAON Inc.(AAON)

Advisors’ Opinion:

  • [By Ethan Ryder]

    AAON (NASDAQ:AAON) reached a new 52-week high and low on Friday . The stock traded as low as $29.05 and last traded at $30.50, with a volume of 203355 shares trading hands. The stock had previously closed at $31.65.

  • [By Max Byerly]

    AAON (NASDAQ:AAON) – Equities researchers at DA Davidson cut their Q1 2018 earnings per share (EPS) estimates for shares of AAON in a report issued on Wednesday, April 11th. DA Davidson analyst B. Thielman now expects that the construction company will earn $0.24 per share for the quarter, down from their prior forecast of $0.25.

Top 10 Value Stocks To Buy For 2018: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Hot Small Cap Stocks To Watch For 2018

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-869162830&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/869162830/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; LOS ANGELES, CA – NOVEMBER 01: George Springer #4 of the Houston Astros celebrates after hitting a two-run home run during the second inning against the Los Angeles Dodgers in game seven of the 2017 World Series at Dodger Stadium on November 1, 2017 in Los Angeles, California. (Photo by Ezra Shaw/Getty Images)

As I explained on a recent podcast, I love to hit singles and doubles, and occasionally triples.&l;/p&g;

It takes a bit more courage to step outside of the batter&a;rsquo;s box and invest in a small cap REIT that has enhanced volatility.

Small caps have always been viewed as riskier bets than large caps, they often do not have the diverse revenue streams or stable cash flows that allow them to weather difficult economic environments (like their larger-cap counterparts).

Hot Small Cap Stocks To Watch For 2018: Dawson Geophysical Company(DWSN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dawson Geophysical (NASDAQ:DWSN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a research note issued on Monday.

Hot Small Cap Stocks To Watch For 2018: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By ]

    Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

  • [By ]

    2. AbbVie (NYSE: ABBV)
    This favorite stock of Wall Street has been trading above its 50-day simple moving average (SMA) since November 2016. Even the February sell-off did not cause the price to violate support at the 50-day SMA. This tells me one thing: Big money is watching the primary technical indicator and buying every pull back!

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Jon C. Ogg]

    AbbVie Inc. (NYSE: ABBV) is the clear leader among the RA drug class with Humira, but Humira is used for multiple indications, and other biosimilars will soon begin targeting Humira’s expensive price tag. AbbVie has faced some similar share price pressure as well, with the stock trading around $93 after peaking just above $125.

Hot Small Cap Stocks To Watch For 2018: Cadence Design Systems, Inc.(CDNS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Southwest Airlines Inc. (NYSE: LUV) canceled flights across the country in order to inspect the engines of 40 different airplanes. The inspections come a week after a mid-air engine explosion caused the first U.S. air fatality since 2009. Money Morning Executive Editor Bill Patalon breaks down the aftermath of the accident, and explains what it means for both Southwest and Boeing Co. (NYSE: BA).
    The price of Bitcoin pushed back toward $9,000 as the post-tax season breakout continues for the cryptocurrency markets. The total value of the global cryptocurrency market topped $400 billion this morning, a significant recovery from the massive downturn that occurred in the first quarter. As we explained on Saturday, now may be the best time to buy Bitcoin since July 2013. That month was when Money MorningDefense and Tech Specialist Michael A. Robinson went on live television with a bold prediction forBitcoin (BTC), which would be followed by 25,351% gains at the peak of the cryptocurrency’s run. Find out where Bitcoin is heading next, right here.
    Three Stocks to Watch Today: GOOGL, LUV, HAS
    Alphabet Inc. (Nasdaq: GOOGL) leads another busy day of earnings reports on Monday. Wall Street anticipates that the online media giant will report earnings per share (EPS) of $9.21 on top of $24.29 billion in revenue.
    Hasbro Inc. (NYSE: HAS) slumped more than 7.6% in pre-market hours after the company reported earnings. The toymaker reported adjusted EPS of $0.10, well short of the $0.33 expected on Wall Street. The firm also reported weaker-than-expected revenue for the quarter. The firm named Toys ‘R Us as a central reason for poor showing – the company recently liquidated its stores, impacting Hasbro Inc.’s (Nasdaq: HAS) bottom lines.
    Look for earnings reports from Halliburton Co.(NYSE: HAL), Alaska Air Group Inc.(NYSE: ALK), Whirlpool Corp. (NYSE: WHR), TD Ameritrade Holding Corp. (Nasdaq: AMTD), Kimberley-Clark Corp. (NYSE: KMB), Cadence Design Syst

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D
  • [By Motley Fool Staff]

    Cadence Design Systems (NASDAQ:CDNS) Q1 2018 Earnings Conference CallApril 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Casino Stocks To Watch Right Now

Wynn Resorts (NASDAQ:WYNN) (+98%, +4.21%, +14%, +0.44%), the U.S. and Macau gaming company, was the largest contributor to the Fund’s 2017 performance with strong earnings growth in Macau and Las Vegas. Industry gross gaming revenues (GGR) in Macau accelerated in the second half of 2017 well beyond full year GGR growth expectations. With major infrastructure projects moving closer to completion, mass visits and spending increasing, and VIPs returning, concerns about potential over-supply from significant capacity additions in Macau turned into confidence that additional hotel and gaming properties will be well absorbed by the market. Steve Wynn continued to create future value with the Boston resort expected to open in 2019, new development around the Las Vegas golf course, and the chance to pursue casino development in Japan. After the stock more than tripled from its lows two years ago and moved closer to our assessment of the company’s value, we reduced the Fund’s position.

Hot Casino Stocks To Watch Right Now: International Tower Hill Mines Ltd(THM)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Hot Casino Stocks To Watch Right Now: Estee Lauder Companies, Inc. (EL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Est茅e Lauder Companies (NYSE:EL) – Investment analysts at Piper Jaffray lifted their FY2018 earnings estimates for shares of Est茅e Lauder Companies in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst E. Murphy now forecasts that the company will post earnings per share of $4.43 for the year, up from their previous forecast of $4.38. Piper Jaffray has a “Buy” rating and a $152.00 price target on the stock. Piper Jaffray also issued estimates for Est茅e Lauder Companies’ Q4 2018 earnings at $0.52 EPS, Q3 2019 earnings at $1.35 EPS, Q4 2019 earnings at $0.53 EPS, Q1 2020 earnings at $1.46 EPS, Q2 2020 earnings at $1.96 EPS, Q3 2020 earnings at $1.52 EPS and FY2020 earnings at $5.58 EPS.

  • [By Joseph Griffin]

    Est茅e Lauder Companies (NYSE:EL) had its price objective cut by Credit Suisse Group from $162.00 to $156.00 in a report issued on Thursday morning. They currently have an outperform rating on the stock.

  • [By Tyler Crowe]

    With this in mind, I thought I would share three companies that I recently added to my portfolio: uniform rental company Cintas (NASDAQ:CTAS), beauty and personal care product retailer Estee Lauder Company (NYSE:EL), and global market maker Intercontinental Exchange (NYSE:ICE). Here’s why I think they are great investments and why they made it into my portfolio.

  • [By ]

    “I was mulling over just this concept,” Cramer continues, “until we got quarterly earnings last week from Est茅e Lauder Cos. (EL)  . The company’s results seemed like a throwback to the good old days, where you got genuine growth through innovation, share take and emerging markets.”

Hot Casino Stocks To Watch Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on AbbVie (ABBV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Keith Speights]

    AbbVie (NYSE:ABBV) ended 2017 with a bang, posting tremendousfourth-quarter results in January. The company has started 2018 with a bang, too.

    On Thursday, AbbVie announced its Q1 earnings results. Wall Street analysts thought the company would report revenue of $7.6 billion. AbbVie’s actual revenue total was $7.9 billion. Analysts expected adjusted earnings per share (EPS) of $1.79. AbbVie reported adjusted EPS in Q1 of $1.87.

  • [By Michael A. Robinson]

    In our chat on Feb. 27, I noted that AbbVie Inc. (NYSE: ABBV) just boosted its dividend by 35%. And I promised I would follow up with a list of more big winners.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

  • [By Cory Renauer]

    AbbVie Inc. (NYSE:ABBV), Pfizer Inc. (NYSE:PFE), and Merck & Co.(NYSE:MRK)are developing drugs that could drive profits, and their share prices, through the roof in the years ahead. Of course, there are plenty of reasons things might not work out as planned.

Hot Casino Stocks To Watch Right Now: Helmerich & Payne, Inc.(HP)

Advisors’ Opinion:

  • [By Chris Johnson]

    Let me show you…

    I Love Helmerich & Payne Inc. (NYSE: HP) for This Coming Week

    My trading model is practically screaming to recommend this contract petroleum drilling company.

  • [By ]

    Only 10% of the companies on the list had female CEOs at the helm, four of which — Hewlett Packard (HP) , Lockheed Martin (LMT) , General Motors (GM) , and General Dynamics (GD) — grew significant revenue in five years or less. 

  • [By ]

    The third caller had Boeing (BA) , Helmerich & Payne (HP) , Fiat Chrysler (FCAU) , LAM Research (LRCX) and Steel Dynamics (STLD)  as her top five stocks.

3 Dividend Stocks for In-the-Know Investors

Finding dividend stocks that provide the right amount of growth, long-term stability, and consistent yields can be difficult. But they aren’t impossible to find, if you know where to look.

To help you track down a few of these companies for your portfolio, we reached out to some Motley Fool contributors for dividend stock ideas. They came back with Uniti Group (NASDAQ:UNIT), AbbVie (NYSE:ABBV), and American Tower (NYSE:AMT). Here’s why.

A jar filled with coins and labeled "dividends"

Image source: Getty Images.

The best telecom REIT you’ve never heard of

Anders Bylund (Uniti Group): This real estate investment trust currently has a 12.6% dividend yield, which is often a red flag. Extremely high yields tend to come with very low share prices, which in turn is a healthy market reaction to deeply troubled business operations.

But maybe pigs do fly after all. This huge yield seems to stem from a misunderstanding, not some profound insight about impending doom.

It’s true that Uniti is tethered to another company that really does deserve plenty of crimson-flag-waving. Regional telecom Windstream Holdings (NASDAQ:WIN) reported a $2.1 billion net loss over the last four quarters, along with roughly breakeven free cash flow and negative EBITDA (earnings before interest, taxes, depreciation, and amortization) profit. Uniti is the new embodiment of Windstream’s former network infrastructure operations, which were spun out as a stand-alone business three years ago. Since then, Windstream’s future has only darkened, while Uniti has been edging away from its old parent company in many ways.

Sometimes, Uniti is punished for Windstream’s sins. But it’s obvious to me that Uniti walked away from the 2015 separation with the better deal. What we see today is a struggling telecom that spun out its most valuable and effective operations in a Hail Mary attempt to gain some financial stability. In the future, I fully expect Windstream to either go bankrupt or agree to a pennies-on-the-dollar buyout, just to salvage a tiny bit of shareholder and debt-writer value. When that happens, Uniti will go on supplying its services through some 4.8 million miles of fiber-optic network strands and 700 wireless towers, but to a whole new set of clients.

If and when that day comes, Uniti shares will take another big hit as many investors expect the dying Windstream to drag this company down behind it. Maybe I’ll buy more shares at that point, because Uniti’s long-term story is solid.

And in the meantime, you can’t beat that ultragenerous dividend yield.

A top income stock that’s in the bargain bin

Todd Campbell (AbbVie): If you typically don’t invest in healthcare, you might not know that shares in the biopharma giant AbbVie fell out of favor last month, following disappointing news on its solid-tumor cancer drug, Rova-T.

AbbVie had hoped definitive midstage trial data for Rova-T could allow it to file for accelerated approval from the Food and Drug Administration, but unfortunately, the data wasn’t good enough for that to happen. Instead, the company will need to wait until results from future trials are available before it submits Rova-T for approval, and that could mean a wait of a year or more.

The setback caused AbbVie’s shares to fall by more than 20%, but it’s far from a deal-breaker for the company. Importantly, the sell-off could be creating a great opportunity to add this top dividend stock to your income portfolios.

AbbVie inherited Abbott Labs’ dividend track record when it was spun off in 2013, so it’s considered a Dividend Aristocrat. It appears to take that badge of honor seriously, because its quarterly dividend has increased to $0.96 from $0.40 since its initial public offering.

Following the drop in its shares, its forward dividend yield has increased to almost 4%. That’s a healthy dividend for any company, but what really makes AbbVie an interesting buy is that its dividend could continue climbing because of double-digit revenue growth. In Q1 2018, sales grew 21% year over year. And since generic biosimilars to its best-seller, Humira, aren’t expected in the U.S. until 2023, there’s plenty of opportunity for investors to own AbbVie and pocket increasingly larger dividend checks.

A company sending a strong signal to dividend investors

Chris Neiger (American Tower): American Tower may not be a household name, but its business is as ubiquitous as it can get. The company owns more than 160,000 cell tower sites throughout the U.S. and across the globe, and rents out the space to wireless carriers. This means that in the U.S. the top wireless service providers pay American Tower to put up signals on its towers, and when they need more capacity — and carriers always do — they have to fork over more money to American Tower.

The demand for wireless data is poised to increase: From 2016 to 2021, mobile data usage is expected to jump 700%. American Tower benefits by entering into long-term lease agreements; the stability from those contracts allows the company to earn about 99% of its sales from recurring revenue.

The great news for dividend investors is that American Tower is a real estate investment trust (REIT), which means that the majority of its net income is paid out as dividends. So as data usage grows — and revenue and income increase — so do the company’s dividends.

American Tower can experience up and downs in sales and earnings just like any other company, and in the first quarter its revenue climbed 7.8% year over year, but earnings fell 8.8%. But that shouldn’t discourage investors. Management expects full-year 2018 sales to increase by 6% and net earnings to rise by 13% year over year, both at the midpoint of guidance.

The company should also benefit from the ongoing wireless evolution, including the upcoming 5G standard. Carriers are already testing 5G, and as they ramp up usage they’ll have to update and expand their signals on cell towers.

American Tower pays a forward yield of 2.19% right now, and has raised its dividend for a modest, but not insignificant, six consecutive years. If you’re looking for a bet on the future of wireless communication — and want a reliable dividend too — you may want to consider this towering tech play.

Top 5 Clean Energy Stocks To Watch For 2018

November has been a bad month for Clean Energy Fuels (NASDAQ:CLNE). The natural gas refueling company has lost around 10% of its value this month, with most of the decline coming after the company released mixed third-quarter results. I am saying mixed because Clean Energy had missed the top line estimate by around 6.5%, even though it trumped the earnings estimate by $0.02 per share.

What gives?

It looks like investors were disappointed by the fact that Clean Energy reported just 5% increase in revenue from the year-ago period, which was identical to the growth in its volumes. Thus, it is evident that Clean Energy Fuels was unable to take advantage of an improvement in natural gas prices last quarter.

In fact, in the third quarter of 2016, the average Henry Hub Natural Gas spot price was 11% higher as compared to the year-ago period. But, whatever growth that Clean Energy delivered on the top line was volume driven. This can be attributed to the fact that Clean Energy Fuels enters into agreements with its clients to sell gas at fixed price contracts that are subject to a price cap. As such, the company was unable to take advantage of the increase in spot prices.

Top 5 Clean Energy Stocks To Watch For 2018: Surgical Care Affiliates, Inc.(SCAI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Surgical Care Affiliates Inc (NASDAQ: SCAI) shares were also up, gaining 16 percent to $56.55 after UnitedHealth Group Inc. (NYSE: UNH) disclosed that its unit agreed to acquire Surgical Care Affiliates for around $2.3 billion.

Top 5 Clean Energy Stocks To Watch For 2018: Seadrill Limited(SDRL)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, the energy shares climbed 1.48 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 15 percent, and EP Energy Corporation (NYSE: EPE), up 15 percent.

  • [By Lisa Levin]

    Wednesday afternoon, the energy shares climbed 1.59 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 77 percent, and EP Energy Corporation (NYSE: EPE), up 19 percent.

  • [By Lisa Levin] Gainers
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 115 percent to $2.56.
    Seadrill Limited (NYSE: SDRL) gained 77 percent to $0.3935. On Tuesday, a U.S. court approved the company's plan to exit Chapter 11 bankruptcy that includes raising around $1 billion in new debt and equity through a rights offering which will be led by its biggest shareholder.
    DropCar, Inc. (NASDAQ: DCAR) shares climbed 21.4 percent to $2.3301 after the company issued a preliminary Q1 update on its enterprise automotive business. The company disclosed that Q1 B2B automotive volumes rose 163 percent year-over-year.
    Teligent, Inc. (NASDAQ: TLGT) shares jumped 19.7 percent to $3.615 following the FDA approval of Clobetasol Propionate Cream USP, 0.05%.
    IZEA, Inc. (NASDAQ: IZEA) surged 19.1 percent to $2.62. IZEA posted a Q4 net loss of $743,000 on sales of $6.8 million.
    SunPower Corporation (NASDAQ: SPWR) shares gained 15.2 percent to $9.6180. SunPower announced plans to acquire SolarWorld Americas.
    LexinFintech Holdings Ltd. (NASDAQ: LX) climbed 10.2 percent to $15.20.
    CounterPath Corporation (NASDAQ: CPAH) shares rose 8.8 percent to $3.0033.
    Semiconductor Manufacturing International Corporation (NYSE: SMI) gained 8.2 percent to $6.685 after falling 0.80 percent on Tuesday.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) shares climbed 7.2 percent to $5.93.
    Textron Inc. (NYSE: TXT) shares rose 6.7 percent to $63.96 after the company reported stronger-than-expected earnings for its first quarter.
    Sibanye Gold Limited (NYSE: SBGL) gained 6.5 percent to $3.59 after dropping 4.53 percent on Tuesday.
    Calithera Biosciences, Inc. (NASDAQ: CALA) rose 6.3 percent to $6.75 after the company disclosed that the FDA has granted Fast Track designation to CB-839 in combination with cabozantinib for treatment of patients with advanced renal cell carcinoma.
    CSX Corporation (NASDAQ: CSX) gained 6.1 percent to $60.01 after reporting upbeat quarterly earnings
  • [By Money Morning News Team]

    (Nasdaq: CNET)

    $2.95 34.76%
    Seadrill Ltd. (NYSE: SDRL) $0.28 33.81%
    Intelsat Corp. (NYSE: I) $9.11 31.50%
    Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18%
    Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61%
    Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

    As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Paul Ausick]

    SeaDrill Ltd. (NYSE: SDRL) dropped about 19% Tuesday, to post a new 52-week low of $1.02 after closing at $1.26 on Monday. The stock’s 52-week high is $5.50. Volume was nearly double the daily average of around 14 million shares. The offshore drilling company had no specific news.

Top 5 Clean Energy Stocks To Watch For 2018: DragonWave Inc(DRWI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Ubiquiti Networks still having been a strong performer when compared topotential small cap peersCeragon Networks Ltd (NASDAQ: CRNT) andDragonWave, Inc (NASDAQ: DRWI) which have performed pretty poorly:

  • [By Peter Graham]

    A long term performance chart shows Ubiquiti Networks largely headingupwards while small cap peersCeragon Networks Ltd (NASDAQ: CRNT) andDragonWave, Inc (NASDAQ: DRWI) have largely headed the other direction:

  • [By Lisa Levin]

    DragonWave, Inc.(USA) (NASDAQ: DRWI) shares dropped 19 percent to $2.35. DragonWave reported a Q3 loss of $0.72 per share on revenue of $10.2 million.

Top 5 Clean Energy Stocks To Watch For 2018: FLIR Systems, Inc.(FLIR)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

  • [By Teresa Rivas]

    Flir Systems(FLIR) was the biggest loser in the S&P 500 on Tuesday, but the stock recouped all its losses Wednesday, and then some.

    Getty Images

    Flir Systems gained $2.78, or 8.1%, to close at $36.93.

    The company’sdisappointing fourth-quarter earnings report was forgotten when it announced that the U.S. Coast Guard awarded it a $50 million contract. Flir will provide marine electronics systems for more than 2,000 Coast Guard vessels for its Scalable Integrated Navigation Systems 2 (SINS-2) program over a five-year period, with the option for extended delivery for an additional five years.

    Even before the news, Imperial Capital’sEd Mally was bullish on the stock’s prospects, who raised his price target on the stock by $2, to $38:

    Although we believe that some may still consider Flir as just a premier provider of very high-end cameras in the bellies of Bell Helicopters or border towers in a lumpy government sector, this 35-year-old company is a global leader in thousands of infrared detector cores and thermography equipment markets and also provides lower priced products to commercial and consumer security customers as well as other customers.

    Flir is up 2% so far this year.

    Coty(COTY) was the hottest stock in the S&P 500 yesterday.

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

Top 5 Clean Energy Stocks To Watch For 2018: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By WWW.KIPLINGER.COM]

    AbbVie Inc. (ABBV) stock is having a market-beating year with its gain of more than 7%, and the dividend only pads that lead. Slow-but-steady growth is a basic part of the equation.

  • [By George Budwell]

    After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.

  • [By Jon C. Ogg]

    AbbVie Inc. (NYSE: ABBV) is the clear leader among the RA drug class with Humira, but Humira is used for multiple indications, and other biosimilars will soon begin targeting Humira’s expensive price tag. AbbVie has faced some similar share price pressure as well, with the stock trading around $93 after peaking just above $125.

Top 10 Medical Stocks To Own For 2018

Venezuela faces shortages of food, water, medicine, electricity and money.

But its state-run oil company — through a subsidiary — donated $500,000 to President Trump’s inauguration committee on December 22, 2016.

That equals what Pepsi (PEP), Verizon (VZ, Tech30) and Walmart (WMT) donated combined, according to Federal Election Commission records released Wednesday as deadly protests raged across Venezuela. The donation to Trump’s inauguration committee was made by Citgo Petroleum, a subsidiary of Venezuela’s state-run oil company, PDVSA.

The country’s citizens face a litany of crises — from food and medical shortages to extremely violent crime.

“It is an amazing amount of money that could have fed a lot of your population for the month,” says Russ Dallen, managing partner of Caracas Capital, an investing firm based in Miami.

Venezuela’s state-run oil giant, PDVSA, bought Citgo in the 1980s. When the late President Hugo Chavez took power in 1999, Citgo was a huge money maker for the country.

Top 10 Medical Stocks To Own For 2018: Progressive Corporation (PGR)

Advisors’ Opinion:

  • [By Chris Lange]

    Progressive Corp. (NYSE: PGR) is set to report its third-quarter results Tuesday morning as well. The analysts consensus estimates are $0.36 in EPS on revenue of $6.99 billion. Shares were changing hands at $48.67 on Fridays close. The consensus price target is $49.07, and the 52-week range is $30.99 to $49.75.

  • [By Joseph Griffin]

    Trexquant Investment LP bought a new stake in shares of Progressive Co. (NYSE:PGR) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 60,054 shares of the insurance provider’s stock, valued at approximately $3,659,000.

Top 10 Medical Stocks To Own For 2018: The Descartes Systems Group Inc.(DSGX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Thursday.

Top 10 Medical Stocks To Own For 2018: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Kumar Abhishek]

    Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in a massive underperformance. Gilead stock has underperformedeven the iShares NASDAQ Biotech Index ETF (NASDAQ:IBB) which has returned more than 14% during the same period. Gilead stock has been making lower lows and lower highs going into the earnings, indicating a clear downtrend in the stock. The stock hit its 52 week low of $69.78 recently on January 24th, just days ahead of its Q4 earnings result. Gilead Sciences, Incis scheduled to report its Q4 2016 and FY 2016 earnings on 7th of February, after the market close.

  • [By Chris Lange]

    Gilead Sciences Inc. (NASDAQ: GILD) has a PDUFA date for its HIV-1 treatment, bictegravir in combination with emtricitabine/tenofovir alafenamide, set on February 12. Shares of Gilead traded at $81.73 apiece, with a consensus price target of $87.79 and a 52-week range of $63.76 to $89.54.

  • [By Keith Speights]

    AbbVie’s new hepatitis C virus (HCV) drug Mavyretappears to be giving Gilead Sciences (NASDAQ:GILD) a run for its money. In the first quarter, AbbVie’s net HCV revenue came in at $919 million. That total includes both of the company’s HCV drugs, Viekira and Mavyret. But there’s virtually no question that Mavyret is contributing most of AbbVie’s HCV revenue.

Top 10 Medical Stocks To Own For 2018: American Capital Agency Corp.(AGNC)

Advisors’ Opinion:

  • [By Amanda Alix]

    This development will likely give battered mREITs like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) a huge boost as investors begin to feel less panic regarding a tapering of the current QE3 program. Markets have responded to the Summers announcement by soaring skyward, apparently feeling relief and confidence about the fate of the taper.

  • [By Boniface Murigu]

    It’s no secret that mREITs such as American Capital Agency (NASDAQ: AGNC  ) (NASDAQ: AGNC  ) (NASDAQ: AGNC  ) , Annaly Capital Management (NYSE: NLY  ) (NYSE: NLY  ) (NYSE: NLY  ) ,and CYS Investmentshave gone through a very turbulent trading period, with all major players losing a sizable share of market value.

  • [By Amanda Alix]

    It was just about one year ago that QE3 made its debut, and mortgage REITs, particularly agency-only players like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) began moaning about the increased competition for mortgage-backed securities guaranteed by Fannie Mae and Freddie Mac.

Top 10 Medical Stocks To Own For 2018: EV Energy Partners, L.P.(EVEP)

Advisors’ Opinion:

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Medical Stocks To Own For 2018: Advanced Energy Industries, Inc.(AEIS)

Advisors’ Opinion:

  • [By Nelson Hem]

    While short sellers shied away from many of the leading solar stocks between the January 15 and January 29 settlement dates, two companies in particular led that trend. The number of Advanced Energy Industries, Inc. (NASDAQ: AEIS) and Sunedison Inc (NYSE: SUNE) shares sold short shrank by more than 10 percent by the end of the month.

  • [By Max Byerly]

    Advanced Energy (NASDAQ:AEIS) has received an average rating of “Hold” from the eight research firms that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $78.20.

Top 10 Medical Stocks To Own For 2018: Atlantia S.p.A. (ATASF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Top 10 Medical Stocks To Own For 2018: Concho Resources Inc.(CXO)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Concho Resources Inc. (NYSE: CXO) which traded down about 7% at $140.01. The stocks 52-week range is $106.73 to $162.91. Volume was about 3 million compared to the daily average volume of 1.5 million.

  • [By Paul Ausick]

    Concho Resources Inc. (NYSE: CXO) is also rated a Hold with a higher price target of $150. For 2017, Jefferies raised its EPS estimate from $0.33 to $1.32, and for 2018 the estimate was lifted from $2.91 to $3.50. The stock closed at $132.41 on Friday, in a 52-week range of $94.26 to $147.55, and the consensus 12-month target is $167.46.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Concho Resources Inc. (NYSE: CXO) which traded down about 9% at $143.15. The stocks 52-week range is $106.73 to $162.91. Volume was 11.8 million compared to the daily average volume of 1.3 million.

  • [By Ben Levisohn]

    Lear also sees strong “upside potential” forConcho Resources (CXO), Pioneer Natural Resources (PXD) and Newfield Exploration (NFX) as well performance improves in the Permian/STACK, and also writes positively on Devon Energy (DVN).

  • [By Matthew DiLallo]

    Rising acreage prices are causing Permian peers concern that the market is getting too hot. For example, Concho Resources (NYSE:CXO) recently said that it was having difficulty finding a good value in Permian land deals. That’s saying a lot for a company that completed several deals over the past year, including paying $1.625 billion for 40,000 net acres last August, or more than $40,000 per acre. However, with recent deals in the mid-$40,000s per acre, and up to as high as $58,500 per acre, buyers like Concho are growing cautious, which suggests land values might be topping out.

Top 10 Medical Stocks To Own For 2018: MPLX LP(MPLX)

Advisors’ Opinion:

  • [By Tyler Crowe]

    [T]his morning we announced our 2018 capital investment plans for both MPC and MPLX(NYSE:MPLX). This plan remains focus on strengthening the sustained earnings power of the business through growth and margin enhancing projects as well as expanding our more stable cash flow businesses especially Speedway and MPLX. Our capital plan for MPC for 2018 excluding MPLX is $1.6 billion. This plan spending includes $950 million for Refining & Marketing, $530 million for Speedway and $100 million to support corporate activities and other investments.

  • [By Tyler Crowe]

    So in this spirit, I thought I would share with you a stock you may want to consider for your own portfolio because it is one I have recently purchased myself: oil and gas logistics player MPLX LP (NYSE:MPLX). Here’s why I think it is a company worthy of investment and the recent change to the business that compelled me to buy this stock.

  • [By Garrett Cook]

    Lastly, Citi says Marathon Petroleum (NYSE: MPC) and MPLX LP (NYSE: MPLX) remain Buy rated the heels of benefits derived from strong product demand and the NGL recovery.

  • [By Ben Levisohn]

    JPMorgan analyst Phil Gresh and team explain what they got wrong about Marathon Petroleum (MPC), as they cut its rating to Neutral from Overweight following yesterday’s disastrous financial results from MPLX (MPLX):

Top 10 Medical Stocks To Own For 2018: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was AbbVie Inc. (NYSE: ABBV) which traded down about 2% at $95.21. The stocks 52-week range is $63.12 to $125.86. Volume was nearly 14 million compared to the daily average volume of 6.8 million.

  • [By ]

    Pharmaceutical stocks joined the party Wednesday after Trump dredged up drug pricing concerns during his State of the Union address. Every major drug manufacturer retreated yesterday. Eli Lilly & Co. (NYSE:LLY) led the way lower with a decline of more than 5%. Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV) werent far behind with losses of 3%.

Top Medical Stocks To Watch Right Now

On Monday, our Elite Opportunity Pronewsletter suggested going long on small cap healthcare products and services stock Natus Medical (NASDAQ: BABY):

Furthermore, Natus Medical Management has managed to beat earnings and revenue estimates for four out of the last five quarters, providing investors with confidence in their ability to manage the Street’s expectations. Assuming the Company continues its current growth trajectory, we expect at least 22% bottom line growth from this year to next.

Technically, shares of BABY have pulled back following a tremendous run that began in late 2013, which didn’t stall until late 2015. Since then, shares have been range bound off its highs of just over $51 per share. Provided below are both a daily and a weekly chart showing you not only what type of run the stock is capable of making once it finds its footing, but also the wide range its traded within for a little over a year now. As you can see, volume in the stock has once again started to pick up steam, along with bullish price action in anticipation of another sharp move higher.

Top Medical Stocks To Watch Right Now: Brocade Communications Systems Inc.(BRCD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Broadcom Limited (NASDAQ: AVGO) and Brocade Communications Systems Inc. (NASDAQ: BRCD) disclosed a definitive deal through which the former would acquire the latter for $12.75 a share in cash. This would translate into a valuation of about $5.9 billion, including $0.4 billion of net debt.

Top Medical Stocks To Watch Right Now: Kohl’s Corporation(KSS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The next market worry is retail, with shares of Macy’s (M) falling over 14%, Kohl’s (KSS) down 19% and L Brands (LB) sinking more than 7%. 

    Cramer said the good news is that money is not leaving the stock market, it’s simply moving from the new winners back to the old winners, stocks like Facebook (FB) and Apple (AAPL) , two Action Alerts PLUS holdings.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about bullish options activity in Kohl's Corporation (NYSE: KSS). He said traders were buying the May 42.5 calls and they were selling puts to finance the purchase. Najarian believes the stock is going to trade higher into the earnings and he decided to follow the trade. He is planning to hold the position for two to three weeks.

  • [By Joe Tenebruso]

    Other department-store chains, such as Macy’s (NYSE:M), J.C. Penney (NYSE:JCP), and Kohl’s (NYSE:KSS), have also seen their stock prices plummet as they struggle with falling traffic and declining comparable-store sales. Consumer buying habits continue to shift away from their core mall-based operations, with department-store sales down for 11 years in a row, according to data from the Commerce Department.

  • [By Ben Levisohn]

    L Brands surged 11% to $47.85 today, while the S&P 500 rose 0.2% to2,357.49. And while L Brands was the best performer, retailers made up half of the 10 best performing stocks in the benchmark today: Nordstrom (JWN) advanced 2.9% to $44.71, Gap (GPS) jumped 5.1% to $24.06, Kohl’s (KSS) climbed 5.6% to $39.60, andBed Bath & Beyond (BBBY), which reported earnings last night, gained 3.4% to $39.08.

  • [By Paul Ausick]

    Rounding out the top 10 in terms of total installed solar PV capacity are Prologis Inc. (NYSE: PLD) with 108 MWs of installed capacity, Apple Inc.(NASDAQ: AAPL with 94 MWs, Costco Wholesale Corp. (NASDAQ: COST) with 51 MWs, Kohl’s Corp. (NYSE: KSS) with 50 MWs, IKEA with 44 MWs, Macy’s Incl. (NYSE: M) with 39 MWs, General Growth Properties Inc. (NYSE: GGP) with 30 MWs, and tied with 23 MWs, Hartz Mountain and Bed, Bath and Beyond Inc. (NASDAQ: BBBY).

Top Medical Stocks To Watch Right Now: Acxiom Corporation(ACXM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Acxiom Corp. (NASDAQ: ACXM) traded down more than 33% Thursday and posted a new 52-week low of $18.60 after closing Wednesday at $28.05. The stock’s 52-week high is $32.93. Volume was about 25 times the daily average of around 600,000 shares. The company is being hammered after social media giant Facebook said it would change its relationship with data brokers.

Top Medical Stocks To Watch Right Now: Alimera Sciences, Inc.(ALIM)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Thursday, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Alimera Sciences Inc (NASDAQ: ALIM) and Anthera Pharmaceuticals Inc (NASDAQ: ANTH).

  • [By Lisa Levin]

    Alimera Sciences Inc (NASDAQ: ALIM) shares shot up 59 percent to $1.69 after the company reported preliminary Q2 revenue. Alimera Sciences announced preliminary revenue of $9.3 million to $9.5 million.

Top Medical Stocks To Watch Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

  • [By George Budwell]

    Keeping this theme in mind, I think the Dividend Aristocrats AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Medtronic plc (NYSE:MDT) are three outstanding stocks to steady any portfolio during these uncertain times. Here’s why.

  • [By ]

    Pharmaceutical stocks joined the party Wednesday after Trump dredged up drug pricing concerns during his State of the Union address. Every major drug manufacturer retreated yesterday. Eli Lilly & Co. (NYSE:LLY) led the way lower with a decline of more than 5%. Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV) werent far behind with losses of 3%.

  • [By Michael A. Robinson]

    To hear Wall Street tell it, AbbVie Inc. (NYSE: ABBV) drove right into a ditch last month.

    Here’s the thing. The company announced results of a Phase 2 trial on March 22 that were disappointing but hardly fatal. The results mean AbbVie won’t seek fast-track approval for its promising antibody-drug conjugate, Rova-T, but it still expects to be able to take it to market in the near future.

Top Medical Stocks To Watch Right Now: Aerojet Rocketdyne Holdings, Inc. (AJRD)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By William Patalon III]

    So is Aerojet Rocketdyne Holdings Inc. (NYSE: AJRD), the rocket-engine specialist Lockheed has tapped to help develop the “scramjet” engines that will push the Son of Blackbird to six times the speed of sound.

  • [By Rich Smith]

    While Trump’s nuclear tweet appears to have taken some folks off guard, the fact is that the U.S. has been planning a major upgrade and refurbishmentof its nuclear arsenal for quite some time — since at least the early years of the second Obama administration, in fact. As far back as three years ago, we were writing about a U.S. Air Force effort to begin upgrading the nation’s aging fleet of Minuteman III intercontinental ballistic missiles — a contract that Aerojet Rocketdyne (NYSE:AJRD), among others, is counting on to juice its rocket revenues. Rival rocket scientist Orbital ATK (NYSE:OA) is bidding on the same contract, and whether it’s Aerojet or Orbital that eventually ends up winning this piece of the nuclear rearmament project, there should be money aplenty to go around.

  • [By Jim Robertson]

    Small cap rocket stockAerojet Rocketdyne Holdings (NYSE: AJRD) had ended last week almost 20% higher albeit shares are slipping in early trading this morning. Small cap Aerojet Rocketdyne Holdings, formerly GenCorp, Inc,is a world-recognized aerospace and defense leader that provides propulsion and energetics to the space, missile defense and strategic systems, tactical systems and armaments areas, in support of domestic and international markets. Starting out in 1915 as General Tire & Rubber Company in Akron, Ohio, todayAR Holdings’ is headquartered in California with businesses that include Aerojet Rocketdyne and Easton Real Estate at facilities across the United States and in Europe.

Top Healthcare Equipment Companies To Invest In Right Now

A guy walks into a financial adviser’s office and says, “I’ve saved $250,000 and I’d like to retire next week and generate $100,000 a year from my portfolio for the rest of my life. Oh, and I want to buy a $50,000 boat.”

See Also: 8 Things No One Tells You About Retirement

Without missing a beat, the adviser replies, “That will only work if you live no longer than two years.”

The real punchline? It’s not a joke. This is a true story. And it highlights a fundamental truth about retirement planning: Many advisers are very good at their jobs, but we’re not magicians.

Top Retirement Concerns

When families first walk into my office to talk about planning for retirement, I usually hear these concerns:

“We’re concerned about running out of money even with our modest lifestyle.” “We’re concerned what we’re currently doing to prepare for retirement won’t work, but we’re scared that doing something else will be worse.” “We’re concerned about the volatility of the stock market, inflation, low interest rates, unexpected health care costs.” “Mostly, we’re concerned about living without a paycheck.”

Here are five time-tested steps that I’ve used hundreds of times to help people like you on their path to retire with confidence.

Top Healthcare Equipment Companies To Invest In Right Now: Bed Bath & Beyond Inc.(BBBY)

Bed Bath & Beyond Inc., incorporated on October 5, 1971, is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market). The Company operates in two segments: North American Retail and Institutional Sales.

The Company’s customers can purchase products from the Company either in-store, online, with a mobile device or through a contact center. The Company also operates Linen Holdings, a provider of a range of textile products, amenities and other goods to institutional customers in the hospitality, cruise line, healthcare and other industries. Additionally, the Company is a partner in a joint venture, which operates approximately seven retail stores in Mexico under the name Bed Bath & Beyond.

The Company sells a range of domestics merchandise and home furnishings. Domestics merchandise includes categories, such as bed linens and related items, bath items and kitchen textiles. Home furnishings include categories, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables and juvenile products.

The Company operates approximately 1,530 stores plus its various Websites, other interactive platforms and distribution facilities. The Company’s over 1,530 stores operate in approximately 50 states, the District of Columbia, Puerto Rico and Canada, including over 1,020 BBB stores, approximately 280 Cost Plus World Market stores, over 100 Baby stores, approximately 80 CTS stores and over 50 Harmon stores. The Company’s stores range in size from approximately 5,000 to 100,000 square feet. The Company has distribution facilities, which ship merchandise to stores and customers, totaling approximately 6.1 million square f eet consisting of over three owned and approximately 10 leas! ed facilities. The Company has approximately 813,000 square feet within over 20 leased and owned facilities for procurement and corporate office functions. In addition, the Company has over seven locations, totaling approximately 14,000 square feet, which are utilized primarily for institutional sales related functions.

Advisors’ Opinion:

  • [By Monica Gerson]

    Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported stronger-than-expected earnings for its fourth quarter and declared its first-ever quarterly dividend of $0.125 per share. Bed Bath & Beyond shares surged 4.49 percent to $51.00 in the after-hours trading session.

Top Healthcare Equipment Companies To Invest In Right Now: Nam Tai Electronics Inc.(NTE)

Nam Tai Electronics, Inc. provides electronics manufacturing and design services to the original equipment manufacturers of telecommunication and consumer electronic products. The company?s Consumer Electronic and Communication Products segment manufactures mobile phone accessories, such as headsets containing Bluetooth wireless technology, and phone cradles, as well as snap-on portable music speaker, FM radio adaptors, and GPS adaptors; entertainment devices, including USB Web cam for interactive games, USB microphone and converter box Karaoke, and buzzer devices for quiz games; educational products consisting of digital pens, calculators, and electronic dictionaries; and optical devices comprising CMOS imaging sensor modules for notebook computers, portable media players, and recording cameras for the automotive industry. Its Telecommunication Component Assembly segment offers subassemblies and components, such as color and monochrome LCD modules for PDA phones, smart p hones, mobile phones, and telephone systems; RF modules for integration into mobile phones; DAB modules for digital radio products, including home tuners, kitchen radios, in-car receivers, CD players, clock radios, boom boxes, midi-systems, and handheld portable devices; FPC subassemblies for LCD modules and electronic devices; FPC boards for mobile phones, PDAs, office automation, and laptop computers; front and back light panels for handheld video game devices; and high-frequency cordless telephones and home feature phones. The company?s LCD Products segment manufactures LCD panels for watches and medical instruments, white goods and industrial applications, automotive parts and appliances, car audio systems, hand held products, VoIP phones, and office automation applications. It sells its products to customers in Hong Kong, North America, Europe, Japan, the People?s Republic of China, and Korea. The company was founded in 1975 and is headquartered in Shenzhen, the Peopl e ?s Republic of China.

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another stock that’s starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world’s leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.

    If you look at the chart for Nam Tai Electronics, you’ll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.

    Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Hot Insurance Companies For 2017: Whiting Petroleum Corporation(WLL)

Whiting Petroleum Corporation engages in the acquisition, development, exploitation, exploration, and production of oil and gas primarily in the Permian Basin, Rocky Mountains, Mid-Continent, Gulf Coast, and Michigan regions of the United States. As of December 31, 2010, its estimated proved reserves were 304.9 million barrels equivalent of oil; and had interests in 9,698 gross productive wells covering approximately 1,115,000 gross developed acres. The company sells its oil and gas to end users, marketers, and other purchasers. Whiting Petroleum Corporation was founded in 1983 and is Denver, Colorado.

Advisors’ Opinion:

  • [By Andrew Efimoff]

    WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:

    California Resources Corporation (NYSE: CRC): -19.22% Dynamic Materials (NASDAQ: BOOM): -12.39% Clayton Williams Energy (NYSE: CWEI): -11.45% Dynergy (NYSE: DYN): -11.91% EP Energy Corporation (NYSE: EPE): -11.20% Mexco Energy (NYSE: MXC) -10.90% Whiting Petroleum (NYSE: WLL) -10.79% Southwestern Energy Company (NYSE: SWN) -10.79% SM Energy Company (NYSE: SM) -10.38% Real Goods Solar (NASDAQ: RGSE) -10.34%

    Posted-In: Commodities After-Hours Center Markets Movers

  • [By Ben Levisohn]

    Shares of energy stocks, including ExxonMobil (XOM), Chevron (CVX), Whiting Petroleum (WLL), and Devon Energy (DVN), are surging on reports that OPEC has agreed to to limit the amount of oil its members produce. Bloomberg’s Nayla Razzouk,Grant Smith, and Angelina Rascouetreport:

Top Healthcare Equipment Companies To Invest In Right Now: AbbVie Inc.(ABBV)

 

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, and Niaspan treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has strategic collaboration with C2N Diagnostics, Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, and Alvine Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illi! nois.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The main conclusions we draw from the abstracts (lacking information about late breakers) is that Gileads dominance of HCV seems secure for the immediate future, with sof/vel (sofosbuvir/velpatasvir) showing impressive efficacy in difficult-to-treat patient subsets. Competitors have early data for their new HCV development efforts (Merck (MRK) [MP], Johnson & Johnson (JNJ) [OP], AbbVie (ABBV)) but will not present new clinical data at this meeting.

  • [By Ben Levisohn]

    After surveying doctors on the preferred hepatitis-C treatments, Baird’s Brian Skorney and Neena Bitritto-Garg contend that Gilead Sciences (GILD) is likely to maintain its dominance over AbbVie (ABBV), Merck (MRK) and Johnson & Johnson (JNJ) but in what appears to be a shrinking market. They explain:

  • [By Ben Levisohn]

    The 20 stocks meeting those requirements are: Ralph Lauren (RL), Time Warner(TWX), Twenty-First Century Fox(FOXA), PepsiCo(PEP), Estee Lauder(EL), Tesoro(TSO), XL(XL), Ameriprise Financial,(AMP), Unum(UNM), Merck(MRK), AbbVie(ABBV), Gilead Sciences(GILD), General Dynamics(GD), Alaska Air(ALK), United Continental(UAL), Delta Air Lines(DAL), Oracle(ORCL), eBay(EBAY), Apple(AAPL), and Centurylink(CTL).

  • [By Ben Levisohn]

    Raymond James analyst Christopher Raymond and team sayAbbVie (ABBV) is “not your father’s biotech company” as they initiate coverage with an Outperform rating:

    Kevin Hagen for The Wall Street Journal

    Initiating coverage of ABBV shares with an Outperform rating and an $82 price target as we think uncertainty over Humira’s intellectual property (IP) creates an opportunity to own this name at a significant discount to its peers before the full extent of the drug’s revenue tail becomes reflected in the stock. Coupling that with a rapidly diversifying portfolio, numerous upcoming value-enhancing catalysts, and a decent dividend yield, we think shares can continue to work higher over the next several quarters.

    Not your father’s biotech company. Having spun out of Abbott Laboratories (ABT) in 2013, and based in North Chicago, IL, AbbVie comes with a decidedly different pedigree than most biotechs. Indeed, most investors we speak with tend to lump the company in with large pharma – simply by virtue of this legacy. However, with a growth profile, product offering, and pipeline that is every bit that of a biotech company, we think this name should increasingly be viewed through such a lens…

    We think the stock can continue to work from here. While Humira still accounts for ~60% of revenue, AbbVie has made great strides toward diversification (with some seen as smart deals, others – the jury is still out), all of which poise the company for significant catalyst flow, in our view. Coupling that with current mid-teens EPS growth, a dividend yield of ~3.5%, and current P/E of ~13x 2016E EPS, we like the set up here.

    Shares of AbbVie are little changed at $64.06 at 3:01 p.m. today, while Abbott Laboratories has declined 0.5% to $42.07.

Top Healthcare Equipment Companies To Invest In Right Now: Protective Life Corporation(PL)

Protective Life Corporation and its subsidiaries engage in the production, distribution, and administration of insurance and investment products in the United States. Its Life Marketing segment markets universal life, variable universal life, level premium term insurance, and bank-owned life insurance products primarily through a network of independent insurance agents and brokers, stockbrokers, and independent marketing organizations. The company?s Acquisitions segment focuses on acquiring, converting, and servicing life insurance policies and annuity products sold to individuals, which are acquired from other companies. Its Annuities segment markets variable annuity products that offer the policyholder the opportunity to invest in various investment accounts; and fixed annuity products, such as modified guaranteed annuities, single premium deferred annuities, single premium immediate annuities, and equity indexed annuities primarily through broker-dealers, financial ins titutions, and independent agents and brokers. The company?s Stable Value Products segment offers guaranteed funding agreements to special purpose entities; fixed and floating rate funding agreements directly to the trustees of municipal bond proceeds, institutional investors, bank trust departments, and money market funds; and guaranteed investment contracts to qualified retirement savings plans. Its Asset Protection segment primarily markets extended service contracts, and credit life and disability insurance to protect consumers? investments in automobiles, watercraft, and recreational vehicles; and markets a guaranteed asset protection product primarily through a national network of approximately 3,750 automobile, marine, and recreational vehicle dealers. The company was founded in 1907 and is headquartered in Birmingham, Alabama.

Advisors’ Opinion:

  • [By David Sterman]

    My favorite insurers: AIG (NYSE: AIG) (which I discussed a few months ago), Protective Life (NYSE: PL) and Reinsurance Group of America (NYSE: RGA).

Top 10 Shipping Stocks For 2016

Why all the confidence? Well aside from all these pundits coming out saying there is a 100% chance that we are in a recession or that a recession will start before summer the reason is thatthe data doesn’t show it. You can make up indicators that don’t really make sense either in their construction or their interpretations or you can focus on one relatively narrow segment of the economy but none of that actually means we are entering a recession.

If you want to gauge the probability of a recession it might be helpful to really study the business cycle and how we enter and exit recession as well as how we do not. You then want to build a battery of models to help you interpret what is happening and what is likely to happen going forward. If you do this, and don’t focus on just one indicator, you will be far better off than what most pundits do.

Top 10 Shipping Stocks For 2016: BioAmber Inc.(BIOA)

 

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The companys bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, and food additives, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine. The company sells its products directly to its customers and commercial partners, as well as indirectly through distributor in the Asia-Pacific region. It has strategic relationships with various companies, including PTTMCC Biochem Company Limited, Vinmar International Ltd., and Mitsubishi Chemical Corporation. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.

Advisors’ Opinion:

  • [By Markus Aarnio]

    BioAmber (BIOA) is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products.

Top 10 Shipping Stocks For 2016: AbbVie Inc.(ABBV)

 

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, and Niaspan treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has strategic collaboration with C2N Diagnostics, Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, and Alvine Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illi! nois.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The main conclusions we draw from the abstracts (lacking information about late breakers) is that Gileads dominance of HCV seems secure for the immediate future, with sof/vel (sofosbuvir/velpatasvir) showing impressive efficacy in difficult-to-treat patient subsets. Competitors have early data for their new HCV development efforts (Merck (MRK) [MP], Johnson & Johnson (JNJ) [OP], AbbVie (ABBV)) but will not present new clinical data at this meeting.

Top 5 Recreation Companies To Own In Right Now: Intuit Inc.(INTU)

 

Intuit Inc. provides business and financial management solutions for small businesses, consumers, and accounting professionals primarily in the United States, Canada, the United Kingdom, Australia, India, and Singapore. The companys Small Business segment provides QuickBooks financial and business management online services and desktop software; QuickBooks technical support services; financial supplies; and QuickBooks Accountant, QuickBooks Accountant Plus, and QuickBooks Online Accountant, as well as the QuickBooks ProAdvisor Program for the accounting professionals. This segment also offers small business payroll products and services, including online payroll offerings, such as Quickbooks Online Payroll and Intuit Online Payroll; desktop payroll offerings comprising QuickBooks Basic Payroll and QuickBooks Enhanced Payroll; and full service payroll offerings, such as Intuit Full Service Payroll and QuickBooks Assisted Payr oll. In addition, it provides merchant services, including credit and debit card processing; Web-based transaction processing services for online merchants; online payment services; GoPayment mobile payment processing services; and QuickBooks point of sale solutions. Its Consumer segment provides TurboTax income tax preparation products and services; and electronic tax filing services. The companys Professional Tax segment offers Lacerte, ProSeries, ProFile, and Intuit Tax Online professional tax products and services; and electronic tax filing services, bank product transmission services, and training services. The company sells its products and services through various sales and distribution channels, including Websites, promotions, call centers, retail locations, and online mobile application stores, as well as through alliance partners, such as banks, credit unions, and other financial institutions. Intuit Inc. was founded in 1983 and is headquartered in Mountain View, California.

Advisors’ Opinion:

  • [By Alex Jordon]

    A variety of acquisitions ramps up Oracle’s presence in cloud computing, like deals with RightNow, Taleo, and Eloqua. The annual run-rate of their cloud business is already over $1 billion, larger than Workday (WDAY) and SAP (SAP) combined. New customers include British Telecom (BT), BMC Software (BMC), Siemens (SI), Yahoo (YHOO), and Intuit (INTU).

Top 10 Shipping Stocks For 2016: Cliffs Natural Resources Inc.(CLF)

Cliffs Natural Resources Inc., a mining and natural resources company, produces iron ore pellets, lump and fines iron ore, and metallurgical coal products. The company operates six iron ore mines in Michigan, Minnesota, and eastern Canada; two iron ore mining complexes in Western Australia; five metallurgical coal mines located in West Virginia and Alabama; and one thermal coal mine located in West Virginia. It also owns a 45% economic interest in a coking and thermal coal mine located in Queensland, Australia; and a 30% interest in Amapa, a Brazilian iron ore project in Latin America, as well as chromite properties in Ontario, Canada. The company, formerly known as Cleveland-Cliffs Inc, was founded in 1847 and is headquartered in Cleveland, Ohio.

Advisors’ Opinion:

  • [By Robert Weinstein]

    Lawsuit after lawsuit, a billion dollars in cost overruns, taxpayer subsidies and the most expensive coal plant to operate causing electric rates to skyrocket, if this becomes the norm. The new project is called Plant Ratcliffe by Southern Co. Plant Ratcliffe is quite the boondoggle, but proponents say it always costs more to build the first one and costs will come down as the technology improves. More plants are in the planning stages and may bring a needed shot in the arm to mining stocks. Alpha Natural Resources (ANR), Walter Energy (WLT), Arch Coal (ACI), Cliffs Natural Resources (CLF), Peabody Energy (BTU), and James River Coal (JRCC) are companies that may benefit from increased demand for coal. Not all coal or coal companies are equal, so it’s crucial to discriminate based on your investment time-horizon goals. With that said, the announcement should have been followed by a deep sell-off in coal and utility related stocks. But something happened. Or, rather, didn’t happen. The above coal stocks didn’t sell off tremendously and are largely moving along with the rest of the market today. This is noteworthy because stocks don’t bottom on good news, they reach a bottom on awful news. Let me explain: When a stock chart continues trending lower, what you’re witnessing is investors throwing in the towel and moving on. Leaving aside bankruptcies for a moment, almost all stocks have a core group of investors that are commonly known as the “strong hands.” A stock is at the bottom when the weak hands are gone. At some point, distressing news (like an unfavorable EPA announcement regarding coal) hits the wire and the related stock or stocks react with little or no movement. This is what we are witnessing right now in coal-related companies.

  • [By Lisa Levin]

    On Thursday, basic materials shares rose by 3.08 percent. Top gainers in the sector included Cliffs Natural Resources Inc (NYSE: CLF), Companhia Siderurgica Nacional (ADR) (NYSE: SID), and Teck Resources Ltd (USA) (NYSE: TCK).

Top 10 Shipping Stocks For 2016: Intrexon Corporation(XON)

 

Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; cell systems informatics; RheoSwitch inducible gene switch; AttSite Recombinases; protein engineering; mAbLogix; and laser-enabled analysis and processing. Intrexon Corporation has collaboration agreements with ZIOPHARM Oncology, Inc.; Synthetic Biologics, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; AquaBounty Technologies, Inc.; S & I Ophthalmic, LLC; Biological & Popular Culture, Inc.; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Janssen Pharmaceutica NV; and strategic coll aboration and licensing agreement with Merck Serono S.A. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Overvalued companies include MWI Veterinary (MWIV) andStericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but callsAratana (PETX) a “hidden gem.”

Top 10 Shipping Stocks For 2016: CRB Futures Index(CR)

Crane Co. manufactures and sells engineered industrial products in the United States and internationally. The company operates in five segments: Aerospace & Electronics, Engineered Materials, Merchandising Systems, Fluid Handling, and Controls. The Aerospace & Electronics segment offers pressure, fuel flow, and position sensors and subsystems; brake control systems; coolant, lube and fuel pumps; and seat actuation products. This segment also provides power supplies and custom microelectronics for aerospace, defense, medical, and other applications; and electrical power components, power management products, electronic radio frequency, and microwave frequency components and subsystems for the defense, space, and military communications markets. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels for the truck trailer and recreational vehicle markets, industrial markets, and the commercial construction industry. The Merchandising Systems segmen t offers vending solutions, such as food, snack, and beverage vending machines; and vending machine software and online solutions, as well as payment solutions, including coin accepters and dispensers, coin hoppers, coin recyclers, bill validators, and bill recyclers. The Fluid Handling segment manufactures and sells various industrial and commercial valves and actuators; provides valve testing, parts, and services; manufactures and sells pumps and water purification solutions; distributes pipe, pipe fittings, couplings, and connectors; and designs, manufactures, and sells corrosion-resistant plastic-lined pipes and fittings. The Controls segment produces ride-leveling, air-suspension control valves for heavy trucks and trailers; pressure, temperature, and level sensors; ultra-rugged computers, measurement and control systems, and intelligent data acquisition products; and water treatment equipment. Crane Co. was founded in 1855 and is based in Stamford, Connecticut.

Advisors’ Opinion:

  • [By Monica Gerson]

    Crane Co. (NYSE: CR) is expected to post its quarterly earnings at $0.86 per share on revenue of $644.60 million.

    Oceaneering International (NYSE: OII) is projected to post its quarterly earnings at $0.35 per share on revenue of $641.85 million.

Top 10 Shipping Stocks For 2016: Formula Systems (1985) Ltd.(FORTY)

 

Formula Systems (1985) Ltd. provides a range of information technology (IT) solutions and services, and develops and markets proprietary software solutions. It offers software solutions and services, such as outsourcing and developing customized software; computer systems management infrastructures, Web world content management, database and data warehouse mining, application integration, database and systems, data management, and software development tools; computer and telecommunication infrastructure solutions; and professional training courses and advanced professional studies. The company also sells personal computers, portable computers, Intel servers, peripheral equipment, operating systems, servers, and workstations; provides computer and peripheral equipment maintenance services, lab, and helpdesk services; and sells and markets cloud based solutions. In addition, it offers Sapiens ALIS, an L&P software solution for i ndividual, group, and worksite insurance products; Sapiens Retirement Services for record-keeping management; Sapiens Closed Books, a solution to administer policies and claims relating to closed books of business; and Sapiens TOPAZ to handle L&P activities and regulations. Further, the company provides Sapiens IDIT for general insurance carriers; Sapiens Insight for business demands at the insurer level and regulatory needs at the state level; Sapiens Reinsurance that enables property and casualty/general insurance carriers and brokers to handle reinsurance activities on a single platform; and Sapiens DECISION, a business decision management solution. Additionally, it supplies professionals in the areas of accounting and finance, administrative, customer service, clinical, scientific and healthcare, engineering, manufacturing and operations, human resources, IT technology, LI/MFG, and marketing and sales. The company was founded in 1985 and is headquartered in Or Yehuda, Is rael.

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, technology shares rose by 0.26 percent. Meanwhile, top gainers in the sector included Applied Materials, Inc. (NASDAQ: AMAT), up 9 percent, and Formula Systems (1985) Ltd. (ADR) (NASDAQ: FORTY) up 19 percent.

Top 10 Shipping Stocks For 2016: Huntsman Corporation(HUN)

 

Huntsman Corporation, together with its subsidiaries, manufactures and sells differentiated organic and inorganic chemical products worldwide. The company operates in five segments: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments and Additives. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, propylene oxide, polyols, propylene glycol, thermoplastic polyurethane, aniline, and methyl tertiary-butyl ether products, which are used to produce rigid and flexible foams, as well as coatings, adhesives, sealants, and elastomers. The Performance Products segment provides amines, carbonates, surfactants, linear alkyl benzene, maleic anhydride, other performance chemicals, ethylene glycol, olefins, and technology licenses. The Advanced Materials segment offers basic liquid and solid epoxy resins; specialty resin compounds; cross-linking, matting, and c uring agents; and epoxy, acrylic, and polyurethane-based formulations. The Textile Effects segment provides textile chemicals, dyes, and inks. The Pigments and Additives segment offers titanium dioxide, functional additives, color pigments, timber treatment, and water treatment chemicals. The companys products are used in various applications, including adhesives, aerospace, automotive, construction products, personal care and hygiene, durable and non-durable consumer products, electronics, medical, packaging, paints and coatings, power generation, refining, synthetic fiber, textile chemicals, and dye industries. Huntsman Corporation was founded in 1970 and is headquartered in The Woodlands, Texas.

Advisors’ Opinion:

  • [By Monica Gerson]

    Huntsman (NYSE: HUN) surged 8.05% to $20.68 in the pre-market session after the company announced its plans to buy Rockwood Holdings’ (NYSE: ROC) Performance Additives and Titanium Dioxide businesses for $1.1 billion in cash.

Top 10 Shipping Stocks For 2016: Brookline Bancorp Inc.(BRKL)

Brookline Bancorp, Inc. operates as the holding company for Brookline Bank, Bank Rhode Island, and The First National Bank of Ipswich, which provide commercial and retail banking services, and cash management and investment services to customers in Central New England. The company accepts various deposit products, including non-interest-bearing checking accounts, interest-bearing NOW accounts, savings accounts and money market savings accounts, certificate of deposit accounts, individual retirement accounts, and other qualified plan accounts. Its loan portfolio comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; auto loans; loans to business entities consisting of commercial lines of credit; and loans to condominium associations, as well as loans for financing equipment used by small businesses. Brookline Bancorp, Inc. also provides financing for construction and development projects, home equity, and other consumer l oans; and loans to finance coin-operated laundry, dry cleaning, and convenience store equipment and businesses. As of January 25, 2012, it operated 43 branches in Massachusetts and Rhode Island. The company was founded in 1871 and is headquartered in Brookline, Massachusetts.

Advisors’ Opinion:

  • [By Dividends4Life]

    Memberships and Peers: PBCT is a member of the S&P 500 and a member of the Broad Dividend Achievers Index. The company’s peer group includes: Bank of America Corporation (BAC) with a 0.3% yield, Brookline Bancorp, Inc. (BRKL) with a 3.7% yield and Westfield Financial Inc. (WFD) with a 3.5% yield.

Top 10 Shipping Stocks For 2016: Nuance Communications Inc.(NUAN)

Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. It offers dictation and transcription solutions and services, which automate the input and management of medical information; and speech recognition solutions for radiology, cardiology, pathology, and related specialties that help healthcare providers dictate, edit, and sign reports without manual transcription. The company also offers mobile and consumer solutions and services comprising an integrated suite of voice control and text-to-speech solutions, desktop and portable computer dictation applications, predictive text technologies, mobile messaging services, and emerging services, such as dictation, Web search, and voicemail-to-text for manufacturers and suppliers of mobile phones, automotive products, personal navigation devices, computers, and other consumer electronics. In addition, it provides customer service business intelligence and authentication solutions for enterprises in the telecommunications, financial services, travel, entertainment, and government sectors to support, understand, and communicate with their customers. Further, the company offers document imaging, print management, and PDF solutions to multifunction printer manufacturers, home offices, small businesses, and enterprise customers; software development toolkits for independent software vendors; and licenses its software to multifunction printer manufacturers. Nuance Communications, Inc. markets and sells its products through direct sales force; its e-commerce Web site; and a network of resellers, including system integrators, independent software vendors, value-added resellers, hardware vendors, telecommunications carriers, and distributors. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in November 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts. Advisors’ Opinion:

  • [By Monica Gerson]

    Nuance Communications Inc. (NASDAQ: NUAN) is projected to post its quarterly earnings at $0.35 per share on revenue of $491.14 million.

    Zebra Technologies Corp. (NASDAQ: ZBRA) is estimated to report its quarterly earnings at $1.22 per share on revenue of $878.67 million.